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Abstract.
1. The aim of this project was to determine whether advancing gestational age and 
parturition were associated with alteration in the relative level of expression of genes 
encoding prostanoid receptors in key uterine and fetal tissues. I also sought to determine 
whether advancing gestational age and parturition were associated with alteration in the 
expression of genes encoding lipoxygenase (LOX) enzymes in key intra-uterine tissues.
2. Caesarean hysterectomy was performed on 15 pregnant baboons in the last third of 
pregnancy. Samples of myometrium (from multiple uterine sites), cervix, decidua and 
chorion were obtained. In addition, the ductus arteriosus was obtained from nine fetal 
baboons, 28 fetal lambs and 4 neonatal lambs. Expression of genes was studied using 
Northern blot analysis and in situ hybridization. Expression of genes was quantified by 
Northern analysis as a ratio of the signal for the gene of interest to each of three 
housekeeping genes (glyceraldehyde-3-phosphate dehydrogenase [GAPDH], beta-actin 
and cyclophilin). Statistical comparison of the effects of gestational age and labour was 
performed using linear regression, Student’s t-test, repeated measures analysis of 
variance and analysis of covariance, as appropriate.
3  Initial studies of animals not in labour using cDNA probes demonstrated transcripts of 
similar size to the human genes for prostanoid EP2, EP3, EP4, and FP receptor mRNA 
using Northern blot in myometrium. Myometrium from the lower uterine segment (LUS) 
had greater expression of EP2 receptor mRNA and less expression of EP3 mRNA 
compared with the fundus and corpus. However, similar levels of EP4 and FP receptor
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mRNA were observed comparing the fundus and LUS. Expression of EP2, EP3 and EP4 
receptor mRNA were also detected in cervix, decidua and chorion. EP2 mRNA was most 
abundant in cervix, EP3 was most abundant in myometrium and EP4 mRNA was most 
abundant in decidua. The variation in myométrial expression of genes encoding EP 
receptor sub-types paralleled the contractile responses of paired samples (reported 
elsewhere).
4 When expression of prostanoid receptor genes was studied in myometrium obtained 
from animals both in labour and not in labour and the techniques employed were 
optimized (principally the use of riboprobes), transcripts of similar size to the human 
genes were detected for prostanoid EPi, EP2, EP3, EP4, IP, FP and TP receptor mRNA 
using Northern blot. There were no gestational age related changes in expression of these 
genes. Expression of EPi, EP3 and IP receptor mRNA was significantly higher in 
myometrium from the fundus (compared with lower segment) whereas EP2 gene 
expression was significantly lower in the fundus. Labor was associated with a reduction 
in the regional variation of both EP2 and IP receptor gene expression, but not EPi and EP3 
expression. Labor was also associated with an overall lower level of expression of EP2 
receptor mRNA.
5 When expression of prostanoid receptor genes was studied in cervix obtained from 
animals both in labour and not in labour, clear signals which were similar in estimated 
size to the human genes were detected by Northern analysis for EPi, EP2, EP3, EP4, FP, 
IP and TP receptors. Expression of the gene encoding the prostanoid EP; receptor 
increased with advancing gestational age prior to labor. Expression of the EP2, FP and TP
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receptor genes was much lower in animals that were delivered during spontaneous labor 
than in animals which were not in labor.
6  When expression of prostanoid receptor genes was studied in decidua and chorion 
obtained from animals both in labour and not in labour, expression of the genes encoding 
the EP] and FP receptor in decidua and the EP4 receptor in chorion was lower with 
advancing gestational age. Expression of the EP2 receptor gene was lower in labour in 
decidua, whereas expression of the IP receptor gene was higher in labour in both decidua 
(2-foId) and chorion (4-fold).
^ Expression of both the EP3 and EP4 receptor genes was detected in lamb ductus 
arteriosus and the level of expression of both genes in the fetal ductus was unaffected by 
maternal administration of corticosteroids. Expression of the EP4 receptor gene was lower 
in the ductus obtained from term lambs compared with preterm lambs, and was lower still 
in neonatal lambs, whereas no variation was observed in EP3 receptor gene expression 
with respect to gestational age and birth. Expression of the EP4 receptor gene was also 
confirmed in fetal baboon ductus arteriosus and maternal administration of corticosteroid 
did not reduce EP4 receptor gene expression in the baboon.
S Signals of similar size to human 5-LOX and platelet 12-LOX genes were detected in 
myometrium, cervix, decidua and chorion. Expression of 5-LOX mRNA decreased with 
advancing gestational age in the cervix. In decidua, expression of 5-LOX mRNA was 
higher in tissues from animals in labor, whereas in chorion, 5-LOX expression was lower
V -
in tissues from animals in labor. Expression of the platelet 12-LOX gene decreased with 
advancing gestational age in chorion and was lower in labor in cervix.
9 Cellular localization of the EP] receptor was possible in myometrium and of the EP4 
receptor gene in ductus arteriosus. In the latter case, expression of the EP4 receptor gene 
was strikingly specific for the ductus arteriosus compared with neighbour vessels. 
Expression of the EP] receptor gene was evident in myométrial smooth muscles cells but 
not in the smooth muscle cells of muscular arteries supplying the uterus.
1 0  The following general conclusions are drawn from these studies:
(a) The myométrial expression of prostanoid receptor genes varies within the uterus and 
the reduced contractile response of LUS to PGE2 is paralleled by greater inhibitory EP2 
receptor expression and less contractile EPi and EP] receptor expression, a similar pattern 
to the cervix.
(b) Regional variation in the expression of prostanoid receptor genes persists in labour 
and suggests a role for regional variation in myométrial sensitivity to prostaglandins in 
the polarity of uterine contraction
(c) The pattern of expression of prostanoid receptor genes varies with advancing 
gestational age in cervix, chorion and decidua. Variation in the sensitivity of these tissues 
to the effects of PGs may have a role in the preparation for parturition in the baboon.
(d) The pattern of expression of prostanoid receptor genes varies in association with 
labour in myometrium, cervix, chorion and decidua. In particular, decreased EP2 receptor 
gene expression was noted in myometrium, cervix and decidua. This implies that
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variation in the sensitivity of these tissues to PGs in general, and to PGE2 in particular, 
might promote parturition in the baboon.
(e) The preparation of the fetus for birth also involved alterations in the relative 
expression of genes encoding contractile and inhibitory EP receptor sub-types. 
Specifically, contraction of the ductus arteriosus at birth may be stimulated by loss of 
inhibitory effects of PGE2 through the EP4 receptor in the presence of maintained 
contractile effects of PGE2 through the EP3 receptor.
(f) Variation in expression of LOX genes may play a role in the onset of parturition in the 
baboon. However, it is not apparent whether the role of LOX is principally to generate 
biologically active products, or to divert free cellular arachidonic acid to relatively inert 
products rather than PGs.
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Chapter 1. Prostaglandins and parturition: a review.
One of the key biological features of mammalian species is viviparity. By necessity, the 
successful completion of the process is essential for propagation of the species. Although 
parturition is common to all mammals, the physiological properties of the process are as 
diverse as mammalian species, which is to say different in many respects but with certain 
common features. Mammalian reproduction in characterized by (1) in vivo fertilization, 
(2) implantation of the conceptus and formation of the placenta, (3) development of the 
embryo, (4) growth of the fetus in an enlarging, essentially quiescent uterus, (5) 
expulsion of live bom young, and (6 ) post-partum contraction of the uterus followed by 
uterine involution.
A detailed review of any aspect of mammalian parturition would require a volume many 
times larger than the whole of this thesis and the aims of this chapter are, first, to give an 
overview of the process of mammalian parturition accompanied with reference to more 
detailed discussion and, secondly, to discuss in greater detail the role of PGs in the 
control of parturition.
1.1 General aspects of mammalian parturition
One of the key differences in the control of parturition comparing mammalian species is 
the role and source of steroid hormones in the control of the process, namely, oestrogen, 
progesterone and corticosteroids '. These hormones have key roles in all species, but the 
source of these hormones and their effects on the process of labour significantly differ. 
Much of the research on the control of parturition has been in littering animals, 
specifically the rat. The reason for its widespread use is largely one of easy maintenance
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in a laboratory setting. More recently the mouse has been a focus for study as it is readily 
utilized for studies of null mutations of its genome. A number of these so-called “knock 
out” experiments have demonstrated that mice which are null mutant for certain genes 
have delayed parturition, including the FP receptor gene cyclo-oxygenase-1 (COX-1)  ^
and steroid 5a reductase type I
While studies in these animals can yield important information about the physiological 
control of parturition in these species, some caution has to be applied when extrapolating 
these results to the human and the attendant clinical problems which are the stimulus to 
much of this research. There are important species differences in the role and source of 
key steroid hormones in the process of labour (see section 1.5.2 for detailed discussion). 
The key factor regulating parturition in rodents is involution of the corpus luteum 
(luteolysis). The corpus luteum is the source of progesterone in these animals and high 
concentrations of progesterone maintain uterine quiescence. Falling concentrations of 
progesterone in these animals, following luteolysis, promote labour. In sheep, 
progesterone has the same role but the source is the placenta. In humans and non-human 
primates, progesterone is also formed in the placenta after the first trimester, but there is 
no change in circulating concentrations of progesterone preceding labour. Many of the 
cellular, autocrine and paracrine mediators are common to rodents and higher species. 
The specific differences are discussed below and have been reviewed elsewhere *. 
Prostaglandins, which are the focus of the present study, are thought to have a key role in 
the process of parturition in all mammalian species studied so far
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1.2. Uterine activity during pregnancy
The activity of the myometrium in pregnancy is frequently misunderstood. The state is 
caricatured as the uterus being quiescent during the antepartum period and then active 
throughout labour. The reality is that the uterine smooth muscle is active throughout 
pregnancy but that the patterns of activity are complex and change with its differing 
physiological roles.
1.2J Ante-partum uterine activity
For obvious reasons, most invasive studies of ante-partum uterine activity have been 
performed in animal species. These studies have revealed that in the ante-partum period 
the uterus exhibits low amplitude, low frequency activity which has been characterized as 
“contractures” This activity is associated with smooth muscle depolarisation, but only 
induces very small increases in intra-uterine pressure and does not result in dilatation or 
effacement of the cervix. This activity does, however, alter the environment of the fetus, 
such as fetal arterial oxygen tension, and the frequency of contractures can influence 
maturation of fetal cardiovascular control systems
L2.2 Intra-partum uterine activity
Uterine activity during labour is characterized by high frequency, high amplitude activity 
which are termed “contractions”. In the human a typical pattern of intra-partum activity 
in the second stage of labour would be four contractions every 1 0  minutes, with a peak 
pressure of up to 60-70mmHg, and a total duration of 60 seconds with the pressure curve 
being bell-shaped From this it is evident that the uterus is only actively generating 
tension for 2 minutes out of every 10. For another 2 minutes it is actively relaxing and for
the remaining 6  minutes out of every 1 0 , the intra-uterine pressure is at basal levels. 
Therefore, considering the uterus as merely moving from a purely passive state before 
labour into a purely active state during labour is not merely an unfortunate simplification, 
but is quite wrong.
Another physiological feature of intra-partum uterine activity is that it is associated with 
polarity, i.e. it is directional, forcing the presenting part of the fetus towards the cervix. 
This suggests that the contractile role of the myometrium during labour is likely to vary 
according to the site of that myometrium within the uterus. The fundus and corpus of the 
uterus would be expected to exert more force than the lower (cervical) pole of the uterus. 
This is another area that has been relatively neglected and is one of the major themes of 
this thesis.
1.2.3 Post-partum uterine activity.
In many considerations of the physiological roles of uterine contraction, post-partum 
uterine activity is neglected or even completely ignored. Yet in the absence of modem 
healthcare (i.e. the evolutionary environment which shaped human physiology), primary 
post-partum haemorrhage (primary PPH, defined as blood loss of greater than 500ml 
within 24 hours of delivery) is one of the major causes of maternal mortality Given that 
failure of post-partum contraction of the utems is the major cause of primary PPH, it is 
clear that development of systems to allow effective post-partum contraction of the uterus 
were central to the evolution of placental reproduction.
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1.3. Prostaglandin pharmacology
Prostaglandins are oxygenated derivatives of arachidonic acid (AA), a fatty acid formed 
from membrane phospholipids by phospholipases. Prostaglandins are generally 
synthesized de novo in the tissue which releases them in contrast to other bioactive 
endogenous agents (such as the monoamines) which are commonly pre-formed and 
stored in intra-cellular vesicles Prostaglandins exert biological effects by acting 
through a family of seven transmembrane domain, G-protein coupled receptors These 
receptors are coupled to a variety of second messenger systems and exert diverse 
biological effects Furthermore, different receptor types and/or sub-types commonly 
exert opposing effects on the same tissue Broadly speaking, PGs act at sites local to 
their site of synthesis. Some PGs, such as TxA% and PGI2 have very short half lives and 
degrade before they exert systemic effects PGE2 and PGFza are more stable, but are 
rapidly broken down in the lungs by 15 (OH) PG dehydrogenase (PGDH) An 
important exception is the fetus, where circulating PGE2 is in the nanomolar range due to 
high levels of PGE2 synthesis from the placenta and low levels of catabolism due to the 
relatively restricted pulmonary blood flow of fetal life All aspects of PG 
pharmacology have been previously reviewed in detail But an overview of the
important aspects is presented below as the pharmacology of PGs is one of the central 
themes of this thesis.
Î.3J  Biosynthesis o f prostaglandins
The main steps in the biosynthesis of prostaglandins (PGs) are: (1) formation of AA from 
membrane phospholipids, either by phospholipase A2 (PLA2) or phospholipase C (PLC), 
(2) the formation of the cyclic endoperoxides, PGG2 and PGH2 from AA by the enzyme
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COX, and (3) the modification of PGH2 to the main native PGs by modifying enzymes, 
such as PGE isomerase, thromboxane (Tx) synthase and PGU-synthase The PG 
pathway is only one of several pathways of AA metabolism which results in biologically 
active products Others include the epoxide pathway (cytochrome P450) the 
isoprostane pathway (non-enzymatic generation of isoprostanes such as 8 -epi- PGp2a) 
and the lipoxygenase (LOX) pathway
1.3.1.1 Phospholipase enzymes
Arachidonic acid is formed enzymatically from membrane phospholipids, principally 
phosphatidyl inositol and phosphatidyl choline. The enzyme PLC forms inositol 
triphosphate and diacylglycerol from phosphatidyl inositol in response to activation of a 
range of G-protein coupled receptors and inositol triphosphate acts on heparin sensitive 
sites to promote intracellular calcium release Diacylglycerol is metabolised by lipases 
to form AA and glycerol. Therefore, AA may be available within the cell following 
stimulation with a range of agonists. It is postulated that AA may itself act as a second 
messenger The other main pathway involved in AA release is PLA2 and this is thought 
generally to be the more important pathway in PG biosynthesis, and it forms AA from 
phosphatidyl choline. A larger molecular weight cytosolic form (CPLA2) and a number of 
smaller secretory forms (SPLA2) have been identified, and these forms differ in their 
calcium concentration dependence
1.3.1.2 Cyclo-oxygenase enzymes
The COX enzyme forms PGH2 from one molecule of AA and two molecules of oxygen. 
The same enzyme catalyses two haeme requiring steps, first, an oxygenase activity
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forming PGG2 and, secondly, peroxidase activity forming PGH2 from PGG2. Two 
isoforms of the enzyme have been identified, COX-1 and COX-2 (see The expression
of COX-1 tends to be fairly constant between cells and in a given tissue in different 
physiological states, and it is frequently referred to as the constitutive isoform. However, 
dynamic up regulation of COX-1 has been described in the uterine artery in association 
with the menstrual cycle and pregnancy Expression of COX-2 varies markedly 
between different tissues and expression in a given tissue may be very significantly 
increased under physiological and pathological situations, such as labour and infection 
COX-2 is frequently referred to as the inducible form of the enzyme, although it does 
play a constitutive role in the physiology of the kidney, brain and endothelium 
The COX enzymes are inhibited by the non-steroidal anti-inflammatory drugs (NSAIDs). 
Aspirin was the first NSAID discovered, but this category of drugs includes an extensive 
range of widely prescribed medicines, including indomethacin, ibuprofen, and diclofenac. 
These drugs are very widely employed as analgesics, anti-pyretics, anti-inflammatories, 
and anti-spasmodics An increasingly large number of drugs are available which 
exhibit selective activity at the two COX isoforms
Null mutant mice (‘knock-outs’) have been described for both isoforms. Mice lacking 
COX-1 exhibit reduced indomethacin-induced gastric ulceration and platelet aggregation 
Furthermore, the majority of pups from matings of homozygous males and females die 
and this appears to be due to delayed parturition^. Mice lacking the COX-2 gene exhibit a 
severe nephropathy and are susceptible to peritonitis These animals are also infertile, 
probably due to failure of ovulation and implantation
1.3.1.3 Metabolism of PGH2
The main naturally occurring PGs which are thought to be of importance physiologically 
are PGI2, PGE2, PGD2, PGp2a and TxA2. Each of these is formed from PGH2 by one (or 
more) enzymes. Since different PGs often have different effects on a given tissue, the 
relative activity of these enzymes may have an important role in determining the 
functional response of a tissue to an increase in free AA. However, a detailed review of 
these pathways is outwith the scope of this thesis and is available elsewhere Key 
enzymes include PGE synthase, PGI synthase and Tx synthase. Some PGs, for instance 
PGE2, can be formed by degradation of PGH2. Furthermore, both PGG2 and PGH2 can 
themselves stimulate the receptor for TxA%'\
1.3.2 Prostaglandin signal transduction
In the 1970s, there was general confusion about the possible existence of receptors for 
PGs. Such classifications as existed were very complex, and some authors postulated 
that PGs did not act through conventional receptors but rather exerted direct effects on 
the cell membrane. The work of Dr Robert Coleman at Glaxo Group Research was 
pivotal in determining the existence of specific receptors for PGs and for understanding 
their physiological roles.
1.3.2.1 Prostanoid receptor pharmacology
Coleman characterised the relative potency of the main naturally occurring PGs in a 
wide range of tissues. These studies suggested that there were receptors for each of the 
main naturally occurring PGs which were at least 10-fold selective for the given PG, and 
he named them after the native PG: EP receptors for PGE2, IP receptors for PGI2, DP
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receptors for PGD%, FP receptors for PGFaa and TP receptors for TxA] In addition, 
using a range of synthetic agonists (and a small number of receptor antagonists), it 
became apparent that there were sub-types of EP receptor. To date, four distinct sub- 
types have been identified and these are numbered 1-4 Broadly speaking, the IP, DP, 
EP2 and EP4 receptors inhibit smooth muscle contractility and the FP, TP, EPi and EP3 
receptors stimulate smooth muscle contractility In addition, activation of these 
receptors influences many physiological processes, including platelet aggregation, renal 
function, thermoregulation, and immune function'^.
Highly selective agonists exist for some of these receptors such as the IP receptor (e.g. 
cicaprost ^^ ), the DP receptor (e.g. BW245C ^^ ), the TP receptor (U46619 ^^ ) and the FP 
receptor (fluprostenol ^^ ). Selective agonists have been developed with activity at the EP2 
receptor (butaprost ^'and AH13205 ^^ ) and the EP3 receptor (GR63799X ^^ ), but not for 
the EPi or EP4 receptors. However, even among these “highly selective” agonists, 
BW245C and GR63799X are agonists of the EP4 receptor in the nanomolar range^ .^ 
Selective antagonists exist for some of the receptors. Many antagonists have been 
described for the TP receptor (e.g. GR32191B BW8 6 8 C is a selective DP receptor 
antagonist AH6809 was originally described as an EPi receptor antagonist but was 
also demonstrated to exhibit DP blocking activity. Both AH23848B and AH13205 
antagonize the EP4 receptor
The “classical” prostanoid receptors described above are of the G-protein coupled class 
with seven transmembrane domains (see below). More recently it has been demonstrated 
that PGs can activate intra-nuclear receptors which mediate effects by altering gene 
transcription The relative contribution of trans-membrane and intra-nuclear
receptors in mediating the biological effects of PGs remains to be determined.
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1.3.2.2 Prostanoid receptor genetics and second messenger coupling 
The functional classification of Coleman has been validated, almost perfectly, by 
molecular biology Genes encoding all eight of the receptor types and sub-types 
identified pharmacologically have been cloned and sequenced in both mice and humans 
When recombinant receptors are expressed in cell systems, they exhibit very similar 
binding profiles to the native receptors and these studies have also served to underline 
the lack of truly specific agonists and antagonists. The characteristics of these receptors, 
the findings in available knock outs, and the chromosomal location of murine prostanoid 
receptor genes is summarized in Table 1.1.
Table 1.1 Characteristics of murine prostanoid receptor genes.
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Gene Phenotype of knock out Second messenger
Chromosomal
Location
DP Failure of mast cell derived asthma"^ ^ AC (positive) 14
EPi Not described IP3 8
EP: Impaired ovulation, hypertension AC (positive) 3
EP3 Impaired febrile response, duodenal 
mucosal dysfunction '^^
AC (negative)
EP4 Neonatal death due to patent ductus 
arteriosus
AC (positive)
FP Failure of luteolysis/parturition IP3 3
IP Thrombophilia, impaired inflammatory 
responses, hypoalgesia
AC (positive) 7
TP Bleeding diatheses IP3 positive 10
AC denotes adenylate cyclase IP3 denotes inositol triphosphate.
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All the receptor types and sub-types which typically inhibit smooth muscle contractility 
have been found to be positively coupled to adenylate cyclase, i.e. the IP, DP, EP: and 
EP4 receptors (Table 1.1). Homology studies have suggested that these receptors form a 
family, probably formed from mutation of a single ancestral gene Of the receptors 
which typically cause smooth muscle contraction, the EPi, FP and TP receptors are 
usually positively coupled to the phosphatidyl inositol cascade, whereas the EP3 receptor 
is usually negatively coupled to adenylate cyclase (Table 1.1).
A number of the currently identified receptor genes form multiple receptor isoforms due 
to alternative messenger ribonucleic acid (mRNA) splicing. The best characterized of 
these is the EP3 receptor and there are at least eight alternatively spliced isoforms of the 
human EP3 receptor The isoforms differ in the COOH terminal of the protein, which is 
the intracellular component of the receptor involved in G-protein coupling. The ligand 
binding site of the isoforms is the same. As stated above, the EP3 receptor is, 
characteristically, negatively coupled to adenylate cyclase. However, transfection of 
different alternatively spliced receptor isoforms into cells demonstrates that different 
isoforms may be positively coupled to adenylate cyclase, or to the phosphatidyl inositol 
cascade It has also been demonstrated that agonist-induced desensitisation appears 
to vary directly with the length of the intracellular component Multiple bands have 
been demonstrated on Northern blot for the TP and IP receptors, and 
pharmacological studies have suggested isoforms of these receptors
1.3.3 Metabolisin o f prostaglandins
Circulating PGs generally undergo rapidly pulmonary degradation: 95% of infused PGE: 
is inactivated in a single passage through the lungs In the fetus, pulmonary blood flow
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is less than 1 0 % of the combined ventricular output and this is one factor which results in 
elevated circulating concentrations ofPGE: in fetal life The initial step of inactivation 
of some prostanoids (e.g. PGI: and TxA:) is spontaneous hydrolysis, as they are very 
unstable. For PGE: and PGF:a, the initial step of inactivation is oxidation of the 15-OH to 
ketone by the enzyme 15-OH-PGDH and further oxidative steps of E series PGs yield 
metabolites which are chiefly excreted in the urine PGDH activity is thought to be a 
major local determinant of local concentrations of PGE: and PGF:a in intra-uterine 
tissues
1.4 Prostaglandins and parturition
Prostaglandins are thought to have a key role in the initiation of parturition in many 
species, including the human and non-human primate ^ Exogenous PGs can induce 
delivery of the conceptus at any gestational age in human clinical situations although 
much lower doses of PGs are required if the administration of PG is preceded by a 
progesterone receptor antagonist such as mifepristone COX inhibitors prolong 
pregnancy and can reverse the altered levels of expression of key genes in 
myometrium in established labour PGs are frequently referred to as a final common 
pathway in the process of parturition and have been implied in both term labour and 
preterm labour arising from diverse aetiologies
1.4.1 Synthesis o f prostaglandins in labour
Increased PG biosynthesis has been described in a number of tissues in association with 
both term and preterm labour. Labour at term is associated with increased circulating 
fetal and maternal concentrations of PGs as well as increased concentrations of PGs
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in amniotic fluid The causal role of these findings in the initiation of labour are 
supported by the fact that these rises appear to precede the onset of labour. Analysis of 
key intra-uterine tissues also demonstrates increased expression of both PLA: and COX- 
2, but not COX-1 Increased expression of these enzymes in the baboon is observed in 
the amnion, myometrium, decidua and cervix and in some of these tissues the increase 
precedes the onset of labour Studies of amniotic fluid PGs also suggest variation 
within the cavity of the uterus, with higher concentrations of PGs in the forewaters (i.e. 
the liquor in the lower pole of the uterus) Consistent with this, myométrial expression 
of COX-2 appears to be greater in samples obtained from the lower pole of the uterus 
than the upper pole in the baboon, and myométrial COX-2 increases in the lower pole in 
late gestation, whereas it does not increase in samples from the fundus 
It is postulated that infection may account for a significant proportion of preterm births 
Clear links between infection, inflammation, and PG synthesis have been demonstrated in 
humans. Amniotic fluid concentrations of PGs appear to be elevated in preterm labour 
associated with infection compared with both idiopathic preterm labour and with preterm 
women not in labour There is an extensive literature on the effects of cytokines on 
expression of key enzymes determining the concentrations of PGs, such as PLA:, COX-2 
and PGDH in cells from key intra-uterine tissues, in particular the amnion The close 
link between inflammation and parturition is underlined by the observation that 
physiological term labour is associated with an infiltrate of inflammatory cells, 
particularly neutrophils and macrophages, and the process of parturition has much in 
common with an inflammatory process
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1.4.2 Effects o f prostaglandins on key intra-uterine tissues
Prostaglandins have important effects on key uterine tissues involved in parturition. A 
number of naturally occurring PGs and synthetic derivatives have effects on myométrial 
contractility. Using a range of these agents, the prostanoid receptors present in 
myométrial strips from the lower uterine segment (LUS) obtained from pregnant women 
at the time of Caesarean section were characterized. These studies demonstrated that 
activation of DP, IP and EP: receptors inhibited myométrial contractility, whereas FP, TP 
and EP] receptor activation stimulated myométrial contractility The study predated the 
identification of the EP4 receptor, and characterization of this receptor is limited by the 
lack of any selective agonist These studies also suggested that the bulk of the 
contractile effect of PGE: on myometrium was mediated by the EP3 receptor, but there 
was also possibly an effect mediated through the EP| receptor. Studies on cultured human 
myométrial cells indicate that EPi, EP3 and FP receptor activation all appear to stimulate 
protein kinase C and calcium influx Interestingly, the intrinsic sensitivity of the EP3 
receptor for PGE: is generally 5 to 10-fold greater than the EP: receptor Consistent 
with this, low concentrations of PGE: have been shown to stimulate myometrium, 
whereas higher concentrations relax myometrium
An important species difference exists between primates and non-primates: both the 
human and baboon exhibit inhibitory responses to selective EP: agonists whereas 
ovine myometrium does not Expression of the gene encoding the EP: receptor 
decreases in association with advancing gestational age in the human and in association 
with labour in the rat Conversely, expression of the gene encoding the excitatory FP 
receptor is increased in labour in both the rat and human
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The factors which regulate prostanoid receptor expression in the uterus in humans and 
non-human primates have not been studied. Studies in the pregnant rat have demonstrated 
that myométrial expression of the EP: receptor gene is unaffected by either exogenous 
oestradiol or by blocking the effects of endogenous oestradiol using the oestrogen 
receptor antagonist ICI 164384 Expression of the FP receptor gene in myometrium 
was increased by exogenous oestrogen or a progesterone receptor antagonist and was 
reduced by exogenous progesterone or an oestrogen receptor antagonist Unlike the 
oxytocin receptor gene, expression of the FP receptor gene was unaffected by stretch 
PGs also have important effects on the cervix and these have been exploited clinically, 
where administration of exogenous synthetic PGE: is widespread for the pre-treatment of 
the cervix prior to induction of labour The effects of PGs on the cervix are thought to 
be due both to associated uterine contraction and to direct effects of PGs on the cervix 
such as decreasing cervical collagen content The receptors mediating the direct effect 
of PGE: on the cervix have not yet been identified.
Both the decidua and fetal membranes are sources of PGs It is assumed that the effects 
of PGs released from these tissues are paracrine, specifically, acting on myometrium 
However, there are minimal data on possible effects of PGs on the fetal membranes or 
decidua. This is partly due to the difficulty in characterizing the effects of hormones on 
these tissues.
1.4,3 Metabolism o f prostaglandins in labour
It is clear that enzymes which are important in the biosynthesis of PGs will have an 
important role in determining local concentration of PGs in key intra-uterine tissues in 
association with labour. In the case of PGI: and TxA: the compounds have very short half
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lives and biosynthesis is likely to be the major determinant of local concentrations. 
However, in the case of PGE: and PGF:a, which are thought to have key roles in 
paiturition metabolism of PGs is also postulated to be important As discussed above, 
the enzyme PGDH catalyses the first step in inactivation of these compounds. Prior to the 
onset of labour, this enzyme is expressed in high levels in the chorion Since the 
chorion lies between the amnion and myometrium and the amnion is seen as the major 
source of PGs for stimulating myométrial contractility, it has been postulated that 
chorionic PGDH may have a key role in regulating parturition. Consistent with this it has 
been shown that both spontaneous term labour and preterm labour in the presence of 
genital tract infection are associated with decreased expression of PGDH in chorion (see 
ref^* for review).
1.4.4 Prostaglandins and fetal cardiovascular adaptation at birth
Preparation for parturition clearly involves preparation of the fetus for life ex utero as 
well as preparation of maternal tissues to expel the fetus. One of the most acute needs of 
the neonate is to establish gaseous exchange through the lungs following loss of the 
umbilico-placental circulation. There are clearly many aspects to this adaptation. One of 
the best understood roles for PGs in this context is in the control of the ductus arteriosus, 
which is a shunt blood vessel of fetal life, extending between the main pulmonary artery 
and the descending aorta. In fetal life, the ductus diverts approximately 90% of the right 
ventricular output away from the lungs to the aorta and, ultimately, to the placenta 
Following birth, the pressure gradient across the ductus reverses and flow is from the 
aorta to the pulmonary artery. Closure of the ductus occurs in the first 24-48 hours of 
fetal life
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Like the utems, PGs have a key role in mediating contraction of the smooth muscle at the 
time of birth. In fetal life, high local and circulating concentrations of PGE: inhibit ductal 
smooth muscle contractility and following birth, circulating concentrations of PGE: fall 
promoting contraction of the vessel The ductus has high intrinsic contractile tone: 
administration of a PG synthesis inhibitor in pregnancy results in contraction of the 
ductus Ductal tone may be related to an intrinsically high sensitivity of the contractile 
proteins to calcium whereas PGE:, acting through adenylate cyclase, inhibits intracellular 
calcium sensitivity in the vessel PGE: relaxes the ductus through the EP4 receptor 
but can also contract the vessel through the EP3 receptor Mice lacking the EP4 
receptor die at birth due to patent ductus arteriosus It is as yet unclear why absence 
of a gene encoding an inhibitory receptor should result in failure of closure of the vessel 
in the neonatal mouse.
Although the pattern of control of the ductus arteriosus by PGE: (PGE: inhibits its 
contractility) is the opposite of myometrium (PGE: stimulates contractility), these two 
smooth muscles exhibit parallels. First, they both express mixed populations of 
stimulatory and inhibitory prostanoid receptor types and EP receptor sub-types. Secondly, 
current models for the control of both smooth muscles tend to focus on factors 
determining the concentration of PGs to which these vessels are exposed. In neither case 
is it yet clear whether variation in the relative expression of prostanoid receptor types and 
sub-types might act have a role in the physiological regulation of contractility.
1.5 Non-prostanoid control of labour
The PG system is only one of many that have been demonstrated to have a role in 
parturition. The process of preterm labour, in particular, may be the result of diverse
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pathophysiological processes, and the relative importance of PGs may differ according to 
the aetiology. Furthermore, many physiological processes have levels of redundancy such 
that elimination of a single system may have relatively little effect on a process to which 
it is laiown to contribute. Thus the phenotypes of many ‘knock out’ mice are surprisingly 
normal. A number of other systems involved in the control of the uterus during 
parturition are discussed below.
L5.1 Oxytocin
Oxytocin is a nine amino acid peptide which contracts myometrium through the 
phosphatidyl inositol pathway and may also stimulate uterine activity by increasing 
COX-2 expression It was first localized in the posterior pituitary, although has been 
more recently identified as being produced in the decidua suggesting autocrine and/or 
paracrine roles in addition to its well described endocrine effects In fact, the possible 
role of oxytocin has been the subject of some debate and some authors maintain its 
effects on the uterus were entirely confined to the stimulation of postpartum contraction 
of the uterus and involution since oxytocin is released from the posterior pituitary in 
association with breast feeding, but circulating levels of oxytocin are not detectably 
elevated prior to the onset of labour Consistent with this view, mice which are null 
mutant for the oxytocin gene have normal labour and delivery, although the neonates die 
due to failure of lactation in the mother However, as well as the normal caveats which 
apply when interpreting these data, species differences in the control of parturition 
undermine extrapolation of this observation to the human. In mice which are null mutant 
for COX-1 and oxytocin, parturition occurs normally whereas mice null mutant for COX- 
1 alone have delayed parturition: this is explained by the opposing luteotrophic effect of
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oxytocin and the luteolytic effect of COX-1 mediated increases in PGFza The 
luteotrophic effect of oxytocin complicates interpretation of the loss of myométrial 
effects of oxytocin in the knock out model.
Synthetic oxytocin has been widely used for many years in the induction of labour and 
management of postpartum haemorrhage. More recently, selective blockers of the 
oxytocin receptor have been developed as uterine tocolytics These agents have 
resolved some of the debate about the role of oxytocin in late gestation and in labour. 
Studies on non-human primates have shown that the oxytocin receptor antagonist 
atosiban inhibits the switch from low amplitude, low frequency contractures, to the high 
amplitude, high frequency contractions of labour at term  ^ and a randomised controlled 
clinical trial demonstrated that the antagonist atosiban had similar tocolytic efficacy to 
ritodrine The discrepancy between the effectiveness of atosiban in inhibiting labour 
and the lack of any rise in circulating concentrations of oxytocin during labour may be 
explained by the drug blocking the autocrine and paracrine effects of decidual oxytocin 
106,111;! 12 yy increase in the number or affinity of oxytocin receptors in key tissues
during labour In the rat, increased expression of oxytocin receptor gene in labour is
mediated both by progesterone withdrawal and mechanical stretch of the uterus
1.5.2 Steroid hormones
The role of steroid hormones differs markedly between species. The key event triggering 
the onset of parturition in rodents is involution of the corpus luteum (luteolysis) which is 
mediated by PGF2« acting through the prostanoid FP receptor Loss of luteal 
progesterone results in parturition. Extrapolation of findings in rodent species to the 
human and non-human primate is limited by the fact that luteolysis has no role in
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parturition in these higher species K In some ruminants, such as the cow, labour is also 
due to PGFia mediated luteolysis resulting in progesterone withdrawal However, in 
sheep, parturition is not related to luteolysis. It was observed that administration of 
corticosteroids to pregnant ewes induced labour and delivery and catheterisation of fetal 
lambs demonstrated that there was a rise in cortisol in fetal blood preceding labour 
The hypothesis that activation of the fetal hypothalamo-pituitary-adrenal axis (HPAA) 
initiates parturition was supported by the observation that labour can be delayed by 
interruption of the HPAA at the level of the adrenal, hypothalamus or para-ventricular 
nucleus Corticosteroids appear to act by inducing placental expression of 17a- 
hydroxylase which converts progesterone to oestradiol The role of this process in 
inducing labour is demonstrated by the observations that labour in the sheep is preceded 
by a sharp rise in maternal circulating concentrations of oestrogen and exogenous 
oestradiol induces labour in the sheep whereas administration of exogenous 
progesterone delays labour Oestradiol stimulates expression of a cassette of genes in 
the uterus which promote contraction
Although sheep and primates share the properties that luteolysis occurs early in gestation 
and progesterone is produced by the placenta there are important differences. For 
instance, there is no fall in progesterone preceding the onset of labour in primates 
Further, administration of exogenous progesterone does not prevent or delay labour 
There is evidence that supports a role for progesterone maintenance of uterine 
quiescence, however, as administration of a progesterone receptor antagonist induces 
uterine contraction, although cervical dilatation is apparently less efficient than in normal 
labour This has given rise to speculation that there may be a progesterone withdrawal 
at the level of its signal transduction system (see below). Furthermore, there is no abrupt
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rise in oestradiol in primates as observed in sheep prior to labour, although there is a 
steady rise in maternal circulating concentrations of oestrogens with advancing 
gestational age in primates Administration of exogenous oestradiol does not induce 
labour in rhesus monkeys However, as in the sheep, a key role has been postulated for 
the fetal HPAA.
The primate (human and non-human) adrenal has a unique fetal zone which produces 
very large quantities of androgenic precursors of oestradiol It is hypothesized that 
stimulation of the fetal adrenal by adrenocorticotrophic hormone (ACTH) may stimulate 
the formation of precursors which are metabolised to oestrogens which in turn promote 
parturition. The hypothesis that androgens from the fetal adrenal might stimulate labour 
was tested by administering exogenous androstenedione to pregnant rhesus monkeys and 
this was associated with preterm labour This would appear to act through the 
formation of oestradiol as co-administration of an aromatase inhibitor (which blocks the 
conversion of androstenedione to oestradiol) blocked the effect of androstenedione 
This seems inconsistent with the observation that exogenous oestradiol on its own did not 
cause labour The difference may be due to a necessity for the formation of oestradiol 
at the site of action. Alternatively, it may be related to effects of androstenedione on 
androgen receptors which are expressed in key intra-uterine tissues 
The control of parturition by steroids in the human appears, as one would expect, to be 
most similar to non-human primates compared with other species. Progesterone has an 
important maintenance function for pregnancy. In the first trimester, the corpus luteum is 
the major source of progesterone but luteolysis occurs early in pregnancy and the 
placenta is the major source of progesterone in the second and third trimesters 
Removal of the corpus luteum after the first trimester does not terminate human
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pregnancy. There is no fail in progesterone preceding labour in women but 
administration of progesterone receptor antagonists can induce delivery in all three 
trimesters, although the successful termination of pregnancy is more commonly 
successful when a PG agonist is administered after the progesterone antagonist 
However, exogenous synthetic progesterone does not inhibit labour in humans 
The effect of progesterone in other species, the effect of progesterone blockade in both 
the human and non-human primate and the lack of effect of exogenous progesterone have 
led to theories that allow a role for progesterone withdrawal in the absence of changes in 
serum concentrations. Possible explanations include altered levels of 17-p,20a- 
hydroxysteroid dehydrogenase resulting in local increases in the ratio of oestrogen: 
progesterone functional antagonism of the progesterone receptor by transforming 
growth factor-p increased expression of heat shock proteins and altered 
expression of progesterone receptor sub-types The relative contribution of these 
multiple pathways affecting the response of the uterus to progesterone in the 
physiological control of parturition remains to be determined.
There is a steady rise in circulating oestrogens with advancing gestation in women 
Oestradiol and oestrone are formed in approximately similar quantities from maternal and 
fetal precursor dihydroepiandrosterone sulphate (DHEAS) whereas oestriol is formed 
principally from fetal DHEAS from the adrenal Release of fetal ACTH may be 
stimulated by the fetal response to pathological stimuli, such as hypoxia 
Alternatively, conversion of maternal cortisol to cortisone by the enzyme lip  steroid 
dehydrogenase may reduce suppression of the fetal HPAA by maternally-derived 
corticosteroid Furthermore, corticotrophin releasing hormone (CRH) from the 
placenta may stimulate ACTH and thus the endocrine changes leading to parturition
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As in the sheep, corticosteroids have important effects on the developing fetus to promote 
lung maturation and other developmental changes to promote adaptation at birth 
These effects are very widely exploited clinically and the use of corticosteroids to 
accelerate fetal lung maturity at the time of threatened preterm delivery is one of a 
relatively small numbers of pharmacological interventions in perinatology which reduced 
the number of perinatal deaths However, unlike the sheep, betamethasone and 
dexamethasone do not induce labour: the human placenta lacks 17-a hydroxylase \  
There are mechanisms, however, by which corticosteroids may influence the process of 
parturition. First, transplacental passage of corticosteroid suppresses the fetal HPAA and 
reduces circulating levels of oestrogens and this prolongs gestation However, 
corticosteroids stimulate release of CRH from the placenta which would tend to 
promote parturition (see below). Secondly, corticosteroids inhibit expression of PGDH in 
placental and chorion cells which will tend to promote parturition These data suggest 
that the cortisol released from the fetal adrenal, although lacking the pivotal role of this 
hormone in the sheep, may influence the process of labour in the human and non-human 
primate.
It is currently assumed that, like the primate, the onset of human parturition is related to 
activation of the fetal HPAA and the combined effects of fetal cortisol and a rise in 
oestrogen mediated by increased precursors from the fetal adrenal. If this is the case, it 
suggests that, as in the rhesus monkey, local production of oestrogen is critical, since 
administration of exogenous synthetic oestrogens to pregnant women does not induce 
labour However, the adverse effects of diethylstilboestrol on the genital tract of the 
developing female fetus has led to considerable caution in evaluating the effects of
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oestrogen receptor agonists to pregnant women and, interestingly, topical oestradiol 
appears to be an effective agent in priming the cervix
L5.3 Corticotrophin releasing hormone
Corticotrophin releasing hormone is a 41 amino acid peptide hormone, first identified in 
the hypothalamus, where it is released into the portal circulation to stimulate release of 
ACTH. Shortly after its identification in the hypothalamus, CRH was demonstrated in the 
human placenta In humans and some -  but not all -  non-human primates, CRH rises 
in the third trimester Release of CRH is stimulated by oestrogen, corticosteroids and 
PGE: and inhibited by progesterone Although CRH does not appear to exert a
direct effect of myométrial contractility expression of the CRH-Rl receptor is 
increased in association with labour The precise role of CRH in the direct control of 
myométrial contractility remains to be determined. However, placentally-derived CRH 
may stimulate myométrial contractility indirectly by activating the fetal HPAA Serum 
concentrations of CRH between 16-20 weeks gestation appear to predict the onset of 
labour at term Furthermore, the relationship between placental CRH and 
inflammation and also with fetal stress suggest that the hormone may have a role in the 
aetiology of preterm labour as well
L5.4 Non-prostanoid eicosanoids
PGs are only one of a number of pathways of locally active agents formed from AA. 
Other enzymatic pathways are the LOX pathway and the epoxide pathway (cytochrome 
P450). I could find no data on the possible role of the epoxide pathway in the control of 
labour. There are a limited number of studies on the LOX pathway. LOX enzymes
-26 -
generate hydroperoxyeicosatetraenoic acid (HPETE) compounds from AA. There are 
three main types of enzyme, 5-LOX, 12-LOX and 15-LOX which generate 5HPETE, 
12HPETE and 15HPETE compounds, respectively. Of these enzymes, it has been shown 
that labour in the human is associated with increased expression of 5-LOX gene and 
protein Consistent with this, 5-HETE has been shown to increase the contractility of 
isolated strips of human myometrium whereas 12-HETE was without effect 
There is another pathway for AA, namely, the non-enzymatic formation of isoprostanes, 
such as 8-epi- PGFia- These agents act both on the TP receptor and on a novel 
receptor and have been shown to have a number of physiological roles in other organs. 
8-epi- PGp2a has been shown to have a moderate stimulatory effect on isolated strips of 
human myometrium but the role of this agent, if any, in the control of parturition is 
unknown.
1.5.5 Other stimulatoty factors
A range of other hormones have been shown to mediate contraction of the uterus. 
Specifically, monoamines, such as 5-hydroxytryptamine, noradrenaline and histamine 
contract isolated strips of myometrium The role of these agents in the control of
labour remains obscure, but it is postulated that release of some of these agents by mast 
cells may promote uterine contraction during labour and may act synergistically with 
other systems, such as PGs
1.5.6 Other inhibitory factors
A  range of other inhibitory factors have been identified which may be involved in 
maintaining uterine quiescence in the antepartum period, for instance, relaxin.
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parathyroid hormone related polypeptide (PTHrP) and nitric oxide. In these cases 
plausible explanations of how these agents may be involved in parturition can be 
elaborated. For instance, in the case of PTHrP, this agent profoundly inhibits the 
contractility of myométrial strips from the uterine corpus, lower segment and fundus of 
the baboon and release of PTHrP from the amnion may be reduced in association with 
labour Despite such associations, information on the causative role of these agents in 
the regulation of parturition remains to be determined.
It cannot be assumed that because an agent has an inhibitory effect on myométrial 
contractility, that its effect is purely to inhibit the process of parturition. In the case of 
both relaxin and nitric oxide (NO), both agents may have effects which promote 
parturition in some key tissues and inhibit parturition in others. Relaxin inhibits 
myométrial contractility but has effects on the cervix which would tend to increase 
cervical compliance Although, synthetic human relaxin is not effective in priming the 
cervix prior to induction of labour increased expression of the gene is implicated in 
preterm, premature rupture of the fetal membranes (PPROM) Similarly, NO donors 
inhibit the contractility of isolated strips of human myometrium and were investigated 
as potential uterine tocolytics in the management of preterm labour However, 
increased activity of endogenous NO is implicated in cervical changes at term and in 
labour and NO donors are effective agents for priming the human cervix prior to 
termination of pregnancy
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L5.7 Changes in cellular function
The above principally deals with specific hormone signalling systems. However, general 
changes also take place in myométrial cellular function which would be expected to 
influence the response of the uterus to these agents.
1.5.7.1 Control of intracellular calcium concentration
Smooth muscle contraction is mediated by the interaction between the 20kDa myosin 
light chain (MLC20) and actin which results in activation of myosin adenosine 
triphosphate (ATP)ase and contraction. The interaction between myosin and actin is 
regulated by phosphorylation of the serine 19 residue on MLC20 Phosphorylation and 
dephosphorylation of this residue is mediated by key regulatory enzymes, myosin light 
chain kinase (MLCK) and a smooth muscle myosin phosphatase (SMPP-IM), 
respectively Raised intracellular calcium concentration ([Ca '^ ]^i) has a key role in
initiating smooth muscle contraction, forming a complex with the regulatory protein 
calmodulin, and the calcium calmodulin complex stimulates contraction by activating 
MLCK
Current models of the control of myométrial contractility invoke a key role for the control 
of intracellular calcium in the regulation of myométrial contractility [Ca^ "^ ]i may be 
elevated either by influx of calcium from the extracellular space or by release of calcium 
from intracellular stores. In human myometrium, agonists induce an increase in [Ca^ "^ ]i 
due both to influx of calcium from the extracellular space and release from intracellular 
stores Influx of calcium from the extracellular space is mediated by both voltage 
sensitive calcium channels and receptor operated channels. The mechanisms which
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regulate [Ca^^i and the relationship between a given [Ca^ ]^; and contraction have been 
reviewed at length
1.5.7.2 Gap junctions
One of the features of intrapartum uterine contraction is that contraction is global, i.e. 
coordinated across the uterus A prerequisite for this is the ability of contraction to be 
propagated through the uterus. In the heart, communication of cells through gap junctions 
results in a functional syncytium. Unlike the heart, the normal state of the uterus is not 
that of a syncytium. However, there is a dramatic increase in the expression of gap 
junctions in myometrium in association with labour which allows excitation of uterine 
cells to be propagated and facilitates global, coordinated uterine contraction
1.5.7.3 G-proteins
Many of the signal transduction systems which are thought to have keys roles in 
stimulating contraction during parturition are of the super-family of G-protein coupled 
receptors G-proteins are membrane associated proteins which bind guanosine 
triphosphate (GTP) and couple occupancy of the receptor by an agonist with activation or 
inhibition of a second messenger In the case of an inhibitory second messenger, such 
as adenylate cyclase, a stimulatory G-protein would mediate relaxation. In the case of a 
stimulatoiy second messenger, however (such as PLC), the same G-protein would 
promote contraction. Conversely, an inhibitory effect of a G-protein on an inhibitory 
second messenger would initiate contraction. The prostanoid EP3 receptor typically 
mediates contraction of smooth muscle in this manner, namely, by a G-protein mediated 
decrease in adenylate cyclase activity Labour is associated with decreased myométrial
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expression of G a  s which stimulates the inhibitory second messenger adenylate 
cyclase. The possible role of variation in G-protein expression in controlling human 
labour is outwith the scope of this thesis and has been reviewed in detail elsewhere
1.5.7.4 Contractile proteins
There is much less information on the possible role of changes in calcium sensitivity (i.e. 
the relationship between [Ca ’^*']i and contractility) in the physiological and 
pharmacological control of myométrial contractility. Studies of human myometrium have 
inferred possible effects of stimulatory agonists on calcium sensitivity from apparent 
dissociations of calcium concentration and force A single study of p-escin
permeabilised smooth muscle demonstrated a greater intrinsic calcium sensitivity of 
human pregnant myometrium compared with non-pregnant which may be related to a 
greater degree of contraction for a given level of activation of MLCK There are, 
however, multiple mechanisms by which the sensitivity of the contractile proteins to a 
given [Ca^ "^ ]; can be altered and these have not been the subject of intense study in 
relation to myométrial activation in labour.
1.6, Clinical aspects of uterine contraction in pregnancy.
1.6.1 Preterm labour
Preterm labour is frequently referred to as if it is a distinct disease. However, it is a 
purely descriptive term, being labour and delivery before the start of the 37‘^  completed 
week following the first day of the last menstrual period. Further, by implication, it is 
arbitrary as well as descriptive. Labour on the 258'*’ day since the LMP is preterm, 
whereas labour on the 259^  ^ day is not. Preterm delivery may be the result of a diverse
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range of clinical precipitating factors including, but not limited to, PPROM, fetal 
abnormality, polyhydrammios, multiple pregnancy, infection, intra-uterine growth 
restriction and uterine anomaly Many cases have no obvious precipitating cause and 
are referred to as idiopathic. Infection is one key antecedent of many cases of preterm 
labour, both with and without PPROM.
The ultimate goal of treating preterm labour is the stated aim of many basic studies of 
myométrial physiology and pharmacology. However, of the three principle clinical goals 
discussed, management of preterm labour is perhaps the one with the most ambiguous 
indication. Preterm labour is undoubtedly a major source of morbidity and mortality. 
Administration of steroids to pregnant women in preterm labour between 1-7 days prior 
to preterm delivery accelerates fetal lung maturation and reduces perinatal morbidity and 
mortality Tocolytic therapy concurrent with steroid administration is justified on the 
grounds that it might delay delivery to allow steroids to have their maximum effect. 
However, although tocolytic therapy does delay delivery, it has no effect on perinatal 
morbidity or mortality The lack of a clear beneficial effect of tocolysis may be related 
to the pathophysiology of preterm labour. For example a significant proportion of cases 
of preterm labour is thought to be secondary to intra-uterine infection and delaying 
delivery is potentially harmful in this context However, preterm labour is the end­
point of diverse pathological processes. It is likely that inhibition of preterm uterine 
contraction confers a differing degree of benefit (or harm) depending on the aetiology.
1.6.2 Induction o f labour
In contrast to the treatment of preterm delivery, induction of labour has been shown, in 
the context of post-dates pregnancy, to reduce both maternal morbidity (Caesarean
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section)‘^  ^ and may also reduce perinatal mortality The apparent protective effect of 
induction of labour post-term on risk of Caesarean section is likely to be due to the 
increased risk of Caesarean section associated with advancing gestational age post-term 
and the apparent reduction in perinatal mortality may be due to the increased risk of 
unexplained stillbirth post term However, at a given gestational age, a woman whose 
labour has been induced is more likely to require a Caesarean section than a woman in 
spontaneous labour The challenge is how to induce labour in a manner than does not 
increase the risk of operative delivery.
1.6.3 Post-partum haemorrhage
Failure of contraction of the uterus postpartum with consequent primary postpartum 
haemorrhage kills approximately 125,000 women in the world each year In this case 
there is no ambiguity in the purpose of treatment: it is to contract the uterus and maintain 
it in a contracted state. An effective, tonic constrictor of the pregnant human uterus that 
has long-term stability at tropical room temperatures would have considerable potential 
to reduce global maternal mortality. However, this aspect of the control of the uterus is 
relatively ignored in the context of myométrial pharmacology.
1.7 Aims of this work.
1.7.1 Variation in myométrial pharmacology according to uterine site 
The vast majority of studies of myometrium from pregnant women use biopsies obtained 
from the lower segment of the uterus, obtained at the time of LUS Caesarean section. It is 
possible to obtain biopsies from the fundus and corpus of the uterus, but only a small 
number of studies use this technique. The alternative to this is to use samples obtained at
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the time of Caesarean hysterectomy. However, this procedure is performed very 
infrequently in modem obstetric practice and, commonly, the indication for this radical 
procedure, e.g. severe atonic PPH, would mean that the results obtained from such 
specimens could not be extrapolated to the physiological situation. One aim of this 
project was, therefore, to address regional variation in gene expression in the primate 
uterus. To this end, the principle technique employed for obtaining tissues was total 
Caesarean hysterectomy.
1.7.2 Identification o f tissue-specific expression ofprostanoid receptors 
Prostaglandins are known to be important in the control of myometrium and cervix in 
labour. Although the decidua and fetal membranes are also sites of PG synthesis, it is 
currently assumed that PGs from these sites have principally a paracrine role by 
influencing the myometrium or cervix. However, it is much harder to characterize 
decidual or chorionic function than myometrium function. The possibility that PGs 
produced in these tissues may have an autocrine effect has not been fully addressed. An 
aim of this project was to determine whether prostanoid receptor expression could be 
demonstrated in the fetal membranes and decidua.
Another aspect of this question related to the complex family of prostanoid receptor types 
and sub-types of EP receptor. Currently, native PGs are typically employed to induce 
labour. The use of PGE? to prime the cervix is dose limited by the effect of PGE2 to 
stimulate myométrial contractility. I sought to determine whether there was evidence that 
prostanoid receptor expression differed in different intra-uterine tissues.
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1.7.3 Identification o f cell-specific expression ofprostanoid receptors
Although analysis of total prostanoid receptor gene expression in a given tissue allows 
inferences to be drawn about the role of a given gene in the control of parturition, this 
approach ignores the cellular complexity of intra-uterine tissues. Even taking the simple 
example of smooth muscle in the uterine wall, there are two types of smooth muscle, 
namely, myométrial and vascular. There are also many other non-muscle cells types, such 
as fibroblasts and leukocytes (the latter infiltrate the uterine wall in association with 
labour). One aim of the project was to determine the cellular localization of prostanoid 
receptor genes.
1.7.4 The effect o f labour on prostanoid receptor expression
A  number of groups have made systematic study of expression of families of genes in 
labour in order to determine systems which are likely to have key roles in the control of 
parturition. These studies have led to the concept of a cassette of genes encoding 
myométrial contraction associated proteins which have a key role in labour. Despite the 
key role postulated for PGs in the control of labour, there has been no systematic study, 
to my knowledge, of the expression of prostanoid receptors in myometrium in any 
species. One aim of this work was, therefore, to describe the effect of labour on 
expression of all eight currently recognized G-protein coupled prostanoid receptors.
As discussed above, I also postulated that prostanoid receptors may have a role in the 
control of other, non-myometrial tissues, in the process of labour. I sought to infer the 
possible role, stimulatory or inhibitory, of prostanoid receptors in other tissues in labour, 
by determining the effect of labour on the level of expression of each of the currently 
recognized prostanoid receptor genes.
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1.7.5 Prostanoid receptor expression in the fetus
Given that successful reproduction necessitates that delivery of the fetus by the maternal 
uterus has coincided with sufficient fetal development to allow independent survival of 
the newborn, it is clear that the processes required for fetal adaptation must mature in a 
parallel fashion with the preparation for labour in uterine tissues. Given that the fetal 
ductus arteriosus, like the uterus, is critically regulated by PGE2, I sought to determine 
whether there were any parallels in developmental changes in prostanoid signal 
transduction in the ductus. I sought, therefore, to determine the effect of advancing 
gestational age and birth on the expression of prostanoid receptor genes in ductus 
arteriosus smooth muscle.
1.7.6 Comparison between prostanoid and related systems
A key role has been postulated for prostanoids in the control of parturition. However, as 
discussed above there are other pathways of AA metabolism which may generate 
eicosanoids with a role in the control of key intra-uterine tissues. While the expression of 
COX enzymes has been systematically studied in relation to labour in a number of 
species, there has been no systematic study of the expression of LOX genes in relation to 
labour in the human and non-human primate. A further aim of this work was, therefore, 
to determine whether expression of LOX genes changed in association with labour in key 
intra-uterine tissues in the baboon.
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Chapter 2. Methods. 
2.1 In vivo methods
All animal work was overseen by the Cornell Institutional Animal Care Committee and 
was under the terms of the current US animal legislation. Baboons were bred in one of 
two facilities in the USA (San Antonio and Chicago) and transferred to Cornell at 
approximately 80 days gestational age (dGA). Gestational age was assessed by a known 
date of mating and by early ultrasonography.
2.1.1 Animal housing conditions
Animals were housed in individual cages. At least 4 weeks prior to study, all animals 
were given a full medical examination to determine that they were in good health. At this 
time they were acclimated to a controlled light: dark cycle and animals which were 
destined for protocols involving chronic instrumentation were fitted to a jacket and tether 
restraint system A nutritionally balanced maintenance diet (Teklad 25% Monkey Diet 
(W) 8663, Harlan Inc., Madison, WI) and water were supplied to animals ad lib. Feed 
was supplemented daily with fresh fruits and/or vegetables and one chewable 
multivitamin tablet daily (Topco, Skokie, IL).
2.1.2 Surgery
All surgical procedures were carried out under general anaesthesia under conditions of 
strict asepsis.
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2.1.2.1 Anaesthesia and pain relief
Anaesthesia was induced by ketamine given by intra-muscular injection. The animal was 
then transfeiTed to an operating theatre and anaesthesia was maintained by inhalation 
using halothane, 1-2 %, initially administered through a face mask and subsequently 
through an endotracheal tube. Post operatively, all animals received analgesia for three 
days (continuous intra-arterial infusion of Buprenorphine [Reckitt & Coleman, Ltd., 
Richmond, VA], 0.03mg.kg'*.day'‘) and prophylactic antibiotics for 5 days (Oxacillin, 
Bristol-Myers Squibb, Princeton, NJ) 100mg.kg‘‘day‘‘) via continuous intravenous 
infusion. All catheters were continuously infused with heparinized saline (25 units of 
heparin.ml"’ at 0.5ml.h'* to the mother and at 0.125ml.h'  ^ to the fetus). Heparinized saline 
was also used as the vehicle for infusion of post-operative medications. When required 
with fetal preparations, the oxytocin antagonist Atosiban (RW Johnson Pharmaceutical 
Research Institute, Raritan, NJ), 0.188g.kg’'.min‘‘ was given to alleviate uterine 
contraction activity.
2.1.2.2 Maternal femoral vein catheterisation
A 3cm incision was made in the long axis of the anatomical course of the femoral artery 
approximately 1cm below the inguinal ligament. The femoral vessels were exposed by 
blunt dissection and the distal end of each vessel was tied. Catheters were advanced into 
the vessel to 15cm, secured to surrounding connective tissue by interrupted 3/0 silk 
sutures, tunnelled subcutaneously to the exit point on the animal’s dorsum and connected 
to the tether system. The skin incision was closed with 3/0 Vicryl.
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2.1.2.3 Laparotomy.
The abdomen was opened through a mid-line incision. This was usually sub-umbilical, 
but occasionally extended above the umbilicus. The length of the incision varied with the 
procedure to be undertaken. Bipolar diathermy was applied to secure haemostasis. The 
rectus sheath was identified and cut in the midline. The linea alba was identified, divided 
in its vertical axis and the two halves of the rectus abdominis separated in this plane. The 
peritoneum was grasped with two small artery forceps, confirmed empty and opened with 
a blade. The peritoneal incision was extended with scissors. Repair was effected using a 
mass closure techniques employing I Vicryl in a continuous suture. The skin was closed 
using sub-cuticular 3/0 Vicryl.
2.1.2.4 Placement of uterine electromyogram (EMG) electrodes.
The abdomen was opened as described above, with an incision of no more than 4cm. The 
anterior surface of the uterus was identified. Five EMG electrodes were stitched into the 
anterior uterine wall. The wires entered a common sheath which was secured to the 
parietal peritoneum on the anterior abdominal wall by a suture. The electrodes were 
connected to the tether system as described for the femoral vascular catheters.
2.1.2.5 Chronic fetal preparations
A detailed description of the techniques involved here is outwith the scope of this thesis 
as fetal preparations are peripheral to the main focus of the work. In brief, the uterus was 
opened with a scalpel and the cut edge was grasped with Babcock forceps. A needle was 
passed through the exposed fetal membranes and amniotic fluid withdrawn and stored at 
42C. The membranes were then excised and grasped with the Babock forceps along with
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the myometrium. When the fetal skin was incised, its cut edge was also incorporated with 
the membranes and myometrium to prevent loss of amniotic fluid. Intra-uterine 
instrumentation varied between preparations. As a minimum it would include an intra­
amnio tic catheter and fetal carotid arterial catheter and variably included jugular venous 
catheter, carotid arterial flow probe, EMG electrodes (biceps and/or triceps), EGG 
electrodes, and tracheal catheter. The catheters, with or without leads, were connected to 
the tether system as described for the maternal instrumentation.
2.1.2.6 Caesarean section.
The abdomen was opened as described above. The uterine incision was transverse 
through the lower part of the uterine corpus. The full thickness of myometrium was 
opened with a blade to expose the fetal membranes and the cut edges of myometrium 
grasped with Babcock’s forceps for haemostasis. At this stage, specimens of amniotic 
fluid were frequently removed. The membranes were then incised and the uterine incision 
extended with scissors. The fetus was delivered, and the cord clamped and divided. The 
fetal membranes were carefully stripped off and the placenta removed intact with gentle 
traction on the umbilical cord. The uterine cavity was explored manually and confirmed 
empty. The uterine incision was closed with a single layer of continuous locked 2/0 
Dexon. Closure was otherwise as described above.
2.1.2.7 Caesarean hysterectomy.
The abdomen was opened as described above and the uterus was incised in the midline. 
After delivery of the fetus, placenta and membranes, the round ligaments were clamped 
and tied. The broad ligament was opened and the peritoneum was opened anteriorly. The
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peritoneal incisions on either side were joined anteriorly and the bladder reflected 
inferiorly to below the level of the cervix. The peritoneum over the posterior aspect of the 
uterus was incised and the inferior cut edge was reflected inferiorly. In this way the 
rectum, if adherent to the Pouch of Douglas, was reflected inferior to the ultimate incision 
in the vagina. The infundibulo-pe 1 vie ligament was then clamped, divided and tied (2/0 
Dexon, lateral to the ovaries if oophorectomy was also being performed). Clamps were 
advanced lateral to the uterus to secure the uterine arteries. These pedicles were cut and 
tied (2/0 Dexon). The cardinal ligaments were then clamped, cut and tied (2/0 Dexon). 
The anterior vaginal wall at the level of the external cervical os was grasped and opened. 
The incision was extended laterally and the vascular angles were clamped. The uterus 
was freed by cutting the posterior wall of the vagina and the specimen was removed for 
immediate harvesting of tissues. The vaginal vault was closed with continuous locking 
2/0 Dexon and the abdomen was closed as described above.
2.1.3 Acquisition o f data from chronically instrumented animals
Maternal and fetal catheters and electrodes exited the animal’s dorsum and entered the 
tether on its jacket. The tether exited the cage and was connected to transducers (for the 
catheters) and pre-amplifiers (for the electrodes). These signals were digitised, averaged 
over 6  second periods, and stored in an electronic form in a computer hard drive. They 
were also printed out on a dot matrix printer to provide a hard copy for each animal. A 
detailed discussion of the electronics of the system is outwith the scope of this thesis and 
has been described elsewhere
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2.2 In vitro methods
All reagents employed were molecular biology grade. Water was ultra filtered, deionized 
to 18.3 MQ resistance and had less than 2 parts of organic impurity per billion. 
Glassware was carefully washed, rinsed with ultra filtered water and baked for at least 5 
hours at 270C. As far as possible, disposable plastic ware was used which was sterile and 
individually wrapped. If it was not, it was autoclaved for 30 minutes. Items which were 
not suitable for either baking or autoclaving were treated with a commercial RNase 
inhibitor (RNase Zap, Ambion, Austin, TX, USA).
2.2.1 Northern blot.
Northern blot is a technique which allows the quantification of a specific ribonucleic acid 
(RNA). The process of Northern blot involves (I) extraction and quantitation of RNA, (2) 
electrophoresis of denatured samples in an agarose gel, (3) transfer of RNA from the gel 
to a solid medium where it is fixed (nitrocellulose or nylon membrane), (4) hybridisation 
of the blot with a labelled probe and (5) autoradiography of the probed blot.
2.2.1.1 Extraction of RNA.
Commercial kits were employed for extraction of RNA which were selective for 
polyadenylated RNA. For samples of less than 0.2g, Micro Fast track, version 2.2 was 
employed and for samples between 0.2 to l.Og, Fast Track, version 2.0, was employed, 
both kits are made by [nvitrogen, San Diego, CA. The overall process is similar for both 
kits and involves homogenisation and incubation of the sample in a buffer containing 
protein/RNase degrader, mixing of the sample with oligo dT cellulose to allow binding of 
polyadenylated RNA to the cellulose, washing of the cellulose pellet to remove protein,
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deoxyribonucleic (DNA) and ribosomal RNA, and then elution of polyadenylated RNA 
from the pellet. The detailed protocol was as follows.
A sample of tissue stored at -80C was placed in a sterile plastic tube containing 200mM 
NaCl, 200mM Tris (pH 7.5), 1.5mM MgC12, 2% sodium dodecyl sulphate (SDS) and 
RNase and protein degrader. The sample was then homogenised for 1 minute and 
incubated at 45C for 1 hour. The specimen was spun at 4000g for 5 minutes, the 
supernatant transferred to a clean labelled tube, 5M NaCl was added and mixed. DNA in 
the specimen was sheared by drawing the sample into a syringe through a 21G needle 4 
times. The oligo dT cellulose pellet was added and the specimen mixed in a rocker for 1 
hour. The suspension was then spun at 3000g for 5 minutes and the pellet washed three 
times in 500mM NaCl, lOmM Tris-Cl (pH 7.5). The pellet was then re-suspended in 
250mM NaCl, lOmM Tris-Cl (pH7.5) and spun at 3000g for 5 minutes and this was also 
repeated 3 times. The cellulose pellet was re-suspended in the same buffer, transferred to 
a spin column and washed three times. The spin-column was transferred to a clean 
microfuge tube and the polyadenylated RNA was eluted by two washes with 200pl of 
lOmM Tris-Cl pH 7.5, heated to 65C. The RNA was precipitated with 0.15 volume of 
2M sodium acetate and 2.5 volumes of 100% ethanol, placed in a -80C freezer until 
solid, thawed and centrifuged at 14,000g for 30 minutes at 4°C and the ethanol removed. 
The pellet of RNA was suspended in 10 mM Tris (pH 7.5) and the concentration and 
purity of RNA determined in a spectrophotometer using the ratio of the optical density at 
260nM and 280nM with a ultraviolet (UV) light source. This procedure typically yielded 
RNA with a 260:280 ratio of 2.1-2.2.
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2.2.1.2 Gel electrophoresis of RNA
The samples of the test RNA and tube containing a standard series of RNA size markers 
(Gibco) were concentrated by centrifugation in a Speed Vac for 10-20 minutes. Each 
pellet was then dissolved in 15 pi of 17.4% (vol/vol) formaldehyde, 50% (vol/vol) 
freshly de-ionised formamide, 20mM MOPS [3-(7/-morpholino)propanesulfonic acid], 
5mM sodium acetate, 0.025% bromophenol blue and ImM ethylenediaminetetraacetic 
acid (EDTA), pH 7.0. Re-suspension was effected by vigorous pipetting and brief 
vortexing. Samples were concentrated at the bottom of the tube by a 5 second spin at 
5000g. They were then heated for 5 min at 65C and chilled on ice for 3 minutes. The 
samples were loaded into wells of a 1.4% (wt/vol) agarose gel containing 0.66M 
formaldehyde, 20mM MOPS and 0.28pg per ml ethidium bromide in an electrophoresis 
tank containing 0.66M formaldehyde and 20mM MOPS. The voltage was generally set at 
100-1 lOV for large gels and 70-80 for small gels. After the electrophoresis was 
completed (typically 3-4 hours), the gel was photographed under UV light (see Figure 
2 . 1).
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Figure 2.1 Photograph of RNA gel, stained with ethidium bromide, following 
electrophoresis and prior to Northern blot. 2pg of myométrial mRNA loaded in each 
lane, except first lane = 2.5 pg of RNA ladder.
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2.2.1.3 Transfer onto membrane
The blot was washed 4 times for 5 minutes in water. The nylon membrane (Gene Screen 
plus, NEN, Dupont, DE, USA) was cut to the size of the gel, washed in water and then in 
lOX SSC (IX SSC is 0.15M NaCl and 0.015M sodium citrate, pH 7.0). The RNA was 
transferred onto the membrane by capillary blotting for 24 hours in lOX SSC. The gel 
was viewed under UV light to confirm that the RNA was transferred. The membrane was 
then washed briefly in 2X SCC and left over night. The process of drying was sufficient 
to fix the RNA onto the membrane. It was stored in a sealed bag at 4C until hybridisation.
2.2.1.4 cDNA probe synthesis
Probes were made from full length human complementary DNA (cDNA). The cDNAs 
were removed from the plasmid by restriction enzymes and separated in a low melting 
point agarose gel. The DNA corresponding to the probe was cut out of the gel and stored 
at -20C. Prior to use, the insert (in gel) was heated at 65C for 10 minutes. cDNAs were 
labelled with [a-^^P] deoxy-cytosinetriphosphate (dCTP) (3000Ci/mmol) using the 
random priming method to specific activities of approximately 1x 1 0  ^ cpm/pg using a 
number of commercial kits, including NEG 013H (NEN, Dupont, Boston, MA, USA), 
Decaprime and StripEZ DNA (both Ambion) using a method described in detail 
elsewhere All kits used the same principle of denatured cDNA in an appropriate 
buffer with random decamers, deoxynucleoside mixture (dATP, dGTP and dTTP, [a-^^P] 
dCTP and large fragment DNA polymerase. Labelled and unlabelled DNA were then 
separated from unincorporated nucleotide using Sephadex G-50 chromatography. The 
probe was quantified in a scintillation counter and, prior to use, was boiled for 5 minutes 
and chilled on ice for 3 minutes. The advantage of the Decaprime kit over the NEG kit
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was that it required less template DNA resulting in less unlabelled DNA in the final 
probe. The advantage of the StripEZ DNA kit was that one of the nucleotides was 
chemically modified allowing the probe to be removed with stripping solutions at 65C 
with minimal loss of blotted RNA.
2.2.1.5 cRNA probe synthesis
The prostanoid receptor cDNAs had been cloned into the pcDNA-3 vector (Invitrogen), 
which includes promoters for phage polymerases SP- 6  and T-7, allowing synthesis of 
sense and anti-sense riboprobes. The plasmid was linearized by an appropriate restriction 
enzyme for the given promoter and type of probe. Probes were synthesized using a 
commercial kit (StripEZ RNA [Northern] or MaxiScript [in situ], both Ambion, TX, 
USA) and labelled with [a-^^P] uracil triphosphate (UTP) (800Ci/mmol) (NEN Life 
Science) for Northern analysis and with ^^ S UTP (1250Ci/mmol) for in situ hybridization 
(see below). In both kits, the linearized plasmid is incubated in appropriate buffer 
(containing DTT and spermidine); unlabelled ATP, CTP and GTP; labelled UTP; the 
appropriate RNA polymerase and a ribonuclease inhibitor. The StripEZ RNA kit differed 
in that one of the unlabelled nucleotides was modified and this allowed the probe to be 
stripped using commercially supplied buffers at 65C with minimal loss of blotted RNA. 
Template DNA was removed by addition of 2U of RNase-free DNase and incubation for 
15 minutes at 37C. Probes was separated from unincorporated nucleotide using a 
Sephadex G-50 spin column (Probe Quant G-50, Pharmacia Amersham) and quantified. 
Unlabelled competitor complementary RNA (cRNA) was synthesized using a 
commercial kit (MegaScript, Ambion) which was optimized for large scale synthesis of
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RNA, allowing the unlabelled competitor to be added in greater than 100-fold excess to 
the labelled probe as a control when employing in situ hybridization (see below).
2.2.1.6 Source of cDNAs
The human EP2 receptor cDNA was obtained from Dr D.F. Woodward of Allergen, 
Irvine, CA 92713, USA. The human prostanoid receptor EP3, EP4 , IP and FP cDNAs 
were obtained from Dr Mark Abramovitz of Merck Frosst, PO Box 1005, Quebec H9R 
4P8 , Canada. The human TP receptor cDNA was obtained from Oxford Biomedical (MI, 
USA) and the mouse EP, receptor cDNA was obtained from Dr Y Sugimoto of Kyoto 
University, Japan. The plasmids (all TRIscript, Ambion) containing the glyeeraldehyde- 
3-phosphate dehydrogenase (GAPDH), beta-actin and cyclophilin cDNAs with RNA 
polymerase promoters were purchased from Ambion. The cDNAs for human 5-LOX, 
platelet 12-LOX, and 15-LOX and for murine leukocyte 12-LOX were all purchased 
from Oxford Biomedical.
2.2.1.7 Hybridisation and washing
Blots were pre-hybridised and hybridised in the same buffer except the latter contained 
the nucleic acid probe. In initial experiments using cDNA probes, hybridisation buffer of 
the following composition was employed: freshly de-ionised foiTnamide (50% vol/vol), 
sodium phosphate (50mM), NaCl (0.8M), SDS, 2% wt/vol, herring sperm DNA (lOOpg 
/ml), yeast transfer RNA (20pg /ml) and IX Denhardt’s (IX = 1% solution of bovine 
serum albumin [BSA], Ficoll and polyvinylpyrrolidone). In later experiments, 
commercial hybridisation buffer was employed which was also based on 50% formamide 
(Northern Max or Ultrahyb, both Ambion).
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When cDNA probes were employed, pre-hybridisation (>5 hours) and hybridisation (>18 
hours) were carried out at 42C in sealed bags. Blots were washed sequentially in 2X SSC 
at 42C, 0.5X SSC and 0.1%SDS at 65T  (15 minutes), and 0.2X SSC and 0.1%SDS at 
room temperature (10 minutes). When cRNA probes were employed, pre-hybridisation 
(>1 hour) and hybridisation (>18 hours) were carried out at 65-68C in bottles in a 
hybridisation oven (Hybaid, UK). Membranes were washed at 65C: twice for five 
minutes in 2X SSC and 0.1% SDS and twice for one hour in O.IX SSC and 0.1%SDS. In 
both cases probe was added to the pre-hybridisation buffer to a concentration of 1 million 
counts per minute per ml of buffer. Following washing, Kodak X-Omat film was exposed 
to the membrane with an intensifying screen at -80C. Following autoradiography, 
membranes were stripped according to the manufacturer’s protocol. Densitometric 
analysis of autoradiographic signals was performed by scanning autoradiographs into 
Adobe Photoshop and then using Scan Analysis (Biosoft, Cambridge, UK) to quantify 
signals.
2.2.2 In situ hybridisation
Frozen sections (5-8 microns thick) cut onto commercially prepared poly-l-lysine coated 
slides (Sigma Chemical Company) were fixed in freshly prepared 4% paraformaldehyde 
in 0.1 M phosphate buffer (5 minutes), washed twice in 0.1 M phosphate buffer, immersed 
in triethanolamine (TEA)-HCl (3.71 g TEA, 2ml 6 M NaOH and 198ml of water), pH 8.0 
and then TEA and acetic anhydride (0.25%) for 10 minutes. They were then washed in 
2X SSC for 5 minutes and briefly in 70% ethanol and allowed to air dry. The specimens 
were incubated for 2 hours in a humidified container (55C) with 50-100pl of pre- 
hybridization buffer (50% freshly deionized formamide, 0.3M NaCl, 20mM Tris-HCl
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(pH 8.0), 5mM EDTA, lOmM sodium phosphate buffer (pH 8.0), Ix Denhardt’s solution, 
in RNase free water), and for least 16 hours in hybridization buffer (i.e. pre-hybridization 
buffer plus probe = 1x106 cpm per specimen, between 50-100pl). Control slides were 
hybridized with a sense riboprobe or an antisense probe in the presence of an excess of 
unlabelled competitor. Slides were then washed three times in 4X SSC and 4mM DTT; 
three times in NTE buffer (0.5M NaCl, lOmM Tris-HCl and 5mM EDTA, pH 8.0) at 37C 
(second NTE wash was for 30 minutes with 30|ig/ml Ribonuclease A); 2X SSC and 
ImM DTT; O.IX SSC and ImM DTT at 60C; and, finally 0.1 SSC at room temperature. 
The slides were then dehydrated in a graded series of ethanol: 50%, 85% (both plus 0.3M 
ammonium acetate) and 100%. They were air dried overnight, dipped in emulsion 
(Kodak NTB2) and exposed for 1-4 weeks at 4C. Following developing and fixing they 
were counter stained with haematolxylin and eosin, mounted (Permount) and covered 
with a glass coverslip.
2.2.3 Cell culture
All procedures were carried out using strict aseptic technique. All manipulations of cells 
were performed in a laminar flow hood. All reagents used were tissue culture grade. If 
reagents were not already sterile (e.g. culture medium), they were filter sterilized. All 
reagents employed were obtained from the Sigma Chemical Company, unless otherwise 
stated. Myométrial cells were established in primary culture using the methodology 
described by Casey et al, with certain modifications. Approximately a gram of 
myometrium was obtained at surgery and placed in Hank’s balanced salt solution 
(buffered with HEPES [20mM] and sodium bicarbonate to pH 7.4) containing penicillin 
(lOOOU/ml), streptomycin (1 mg/ml) and amphotericin (2.5pg/ml). The tissue was minced
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into fragments of about Imm^ using two sterile scalpel blades and transferred to Hank’s 
balanced salt solution containing collagenase (type II, Gibco BRL) 2mg/mi, DNase 
(0.2mg/ml = 1400U/ml), penicillin (200U/ml) streptomycin (200pg/ml) and amphotericin 
0.5pg/ml. The tissues was incubated in this solution (with agitation) for 12-16 hours. The 
suspension was then drawn into a 30ml syringe 4 times (to disperse the cells further) and 
filtered through 4 layers of sterile gauze cloth. The filtrate was centrifuged at 600g for 10 
minutes and the pellet suspended Ham’s F-12 Dulbecco’s minimal essential medium 
containing 10% fetal bovine serum (v/v), penicillin (lOOU/ml), streptomycin (0.1 mg/ml) 
and amphotericin (0.25pg/ml). The cells were then placed in a tissue culture flask and 
incubated at 37C in 95% air 5% CO2. The culture medium was changed every 48-72 
hours. Cell growth was assessed by visual inspection using a phase contrast microscope 
and confluence was reached in about 7 days. When confluent, the culture medium was 
removed and replaced with Hank’s balanced salt solution (lacking calcium and 
magnesium) containing HEPES (25mM, pH7.2) and Trypsin-EDTA solution and 
incubated for 10 minutes at 37C until the cells detached. The cell suspension was added 
to two volumes of culture medium, centrifuged for 1 0  minutes at 600g and then re­
suspended in culture medium and pelleted again. The cells were then re-suspended in 
culture medium and counted. The cells were then plated at a density of 100,000 per cm .^
2.3 Statistics
Continuous variables were summarized by the mean and standard error of the mean 
(SEM). Comparison of two means was made by Student’s t-test. Comparison of three or 
more means was made using analysis of variance (ANOVA). Comparison of paired data 
was performed using Student’s paired t-test when comparing two groups and by repeated
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measures ANOVA when comparing three or more groups. Multiple comparisons 
following ANOVA was performed using Tukey’s method. Comparison of means 
adjusted for a continuous covariate was performed using analysis of covariance. 
Correlation was determined using both the Pearson correlation coefficient and by 
Spearman’s rho. Statistical significance was assumed at the 5% level. Statistical analysis 
was performed using SPSS version 9.0 (SPSS Inc, Chicago IL, USA) and Stata version 
6.0 (Stata Corporation, College Station, TX, USA).
- 5 2 -
Chapter 3. Regional and tissue variation in prostanoid receptor gene expression
To deliver the fetus, the uterus must exert force with a degree of polarity to direct the 
baby through the cervix and birth canal, which necessitates a relative relaxation of the 
LUS. Following delivery, however, the whole uterus must contract to prevent 
hemorrhage. Effective delivery of the fetus and contraction of the empty uterus post­
partum are essential for neonatal and maternal survival. But the process by which 
differential, regional control of the uterus is effected is as yet unknown.
I sought to test the hypothesis that differential control of the upper and lower poles of the 
uterus would be reflected in regional variation in the response to PGs and that any such 
variations would in turn be paralleled by regional differences in the expression of 
prostanoid receptor mRNA. Furthermore, given the large family of receptor types and 
sub-types, there is clear potential for the use of selective agonists and antagonists, as 
appropriate, in the clinical situations described section 1.6. Therefore, I also sought to 
describe the pattern of expression of prostanoid receptors in key intra-uterine tissues.
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3.1 Methods.
Caesarean section. hysterectomy was performed on 8  animals at the following days 
gestational age (dGA): 121, 153, 159, 162, 162, 177, 177, 180 (term=180-185 days) and 
samples of myometrium were obtained from different regions of the uterus. The cervix 
was un-effaced and closed in all animals. Uterine electromyogram leads had been sited in 
3 hysterectomy animals going to term (delivered at 177, 177 and ISOdGA). Analysis of 
EMG traces of the 48 hours preceding surgery revealed no contraction activity. No drugs 
of any form had been administered to any of the animals in the 2  weeks preceding 
surgery. Samples were dissected immediately following removal of the uterus and flash 
frozen. The LUS was defined as the portion of the uterus superior to the internal os of the 
cervix. The fundus was defined as the portion of the uterus superior to the upper limit of 
the uterine cavity. Samples from the corpus were obtained from both the anterior and 
posterior wall. Upper and lower corpus were defined as lying above and below 
(respectively) the midline between the upper limit of LUS (which I took as 1cm superior 
to the internal os of the cervix) and the lower limit of fundus. The site of sampling are 
outlined schematically in Figure 3.1.
Northern blot was perfoimed as described in Chapter 2. The composition of the pre­
hybridisation buffer was freshly de-ionised formamide (50% vol/vol), sodium phosphate 
(50mM), NaCl (0.8M), sodium dodecyl sulphate (SDS, 2% wt/vol), herring sperm DNA 
(lOOfig /ml), yeast transfer RNA (20pg /ml) and IX Denhardfs (IX = 1% solution of 
BSA, Ficoll and polyvinylpyrrolidone) and hybridisation buffer was the same with the 
probe added. Random primed DNA probes were used in all Northern blots described in 
this chapter.
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Cervix Anterior Posterior
Figure 3.1 Schematic outline of site of sampling from myometrium. The figure 
represent the appearance of the uterus cut in a longitudinal section in the midline.
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3.2 Results.
A preliminary screen for the eight currently recognized prostanoid receptor types and 
sub-types (EP1.4, DP, IP, TP and FP) using Northern blot analysis and cDNA probes 
identified EP2, EP3, EP4 and FP receptor mRNA in baboon myometrium. Samples of 
RNA from LUS and fundus from the 8  hysterectomies were then analysed for these 
receptors. Compared with fundus, LUS exhibited more EP2 (Figures 3.2A and 3.3A), less 
EP3 (Figures 3.2B and 3.3B) and similar levels of EP4 and FP mRNA (Figures 3.3C and 
3.3D). The corpus also had less EP2 and more EP3 mRNA compared with LUS (Figure 
3.4). There was no correlation between the level of expression of any of these genes in 
either LUS or fundus with the gestational age of the animal at the time of Caesarean 
section.
Northern blot analyses of prostanoid receptor mRNA in myometrium (anterior corpus), 
cervix, decidua and chorion demonstrated EP2, EP3 and EP4 receptor mRNA in all four 
tissues. FP receptor mRNA was only detected in myometrium and cervix (Figure 3.5). 
There was a characteristic distribution of EP receptor mRNA in the four tissues, with the 
EP2 receptor being most abundant in cervix, EP3 most abundant in myometrium and EP4 
most abundant in decidua (Figure 3.6). There was no difference in EP4 or FP receptor 
mRNA comparing myometrium and cervix (Figure 3.6). EPi, IP, DP and TP expression 
were not reliably detected by Northern blot in any of these tissues using cDNA probes, as 
were employed in these analyses.
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Figure 3.2A-B. Northern blot of E? 2  and EP3 expression in lower uterine segment 
(LUS) and fundus from 8  pregnant baboons between 121-180dGA. Variation in 
loading was corrected by subsequent probing of the same blot for GAPDH. Each lane 
was loaded with 2pg polyadenylated RNA (EP3) or 5pg (EP2).
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Figure 3.3. Densitometric quantitation of EPz, EP3 , EP4  and FP receptor mRNA 
relative to GAPDH comparing lower uterine segment (LUS) and fundus.
Densitometry for EP3 was performed on the signal of approximately 2.4kB (see Figure 
2A). Statistical comparison of LUS vs. fundus (means ± SEM, n=8 ) by Student’s t-test,
*p<0 .0 1 .
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Figure 3.4. Densitometric quantitation of EPa and EP3 mRNA in different regions of 
baboon uterus using lower uterine segment (LUS) as a reference. Each lane was 
loaded with 5p.g of myométrial mRNA extracted from one of 6  regions of a single 
animal’s uterus: LUS= lower uterine segment, ACL = anterior corpus lower, ACU = 
anterior corpus upper, PCL = posterior corpus lower, PCU = posterior corpus upper, FUN 
= fundus. Blots were probed for EP2 or EP3 and then for GAPDH. The signal for a given 
probe was expressed as a ratio to the signal for GAPDH. For a given blot, the signals in 
the other 5 regions were expressed as a ratio to the signal in LUS (means ± SEM, n=6-7). 
The data were then pooled and means and 95% Cl were calculated for each region with 
the LUS as unity and a significant difference (*) with LUS was assumed where 95% Cl 
excluded 1 .0 .
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Figure 3.5A-D. Representative Northern blots of EP2 , EP3 , EP4  and FP receptor 
mRNA in myometrium from anterior corpus (MYO), cervix (CX), decidua and 
chorion. Each lane was loaded with lOpg polyadenylated RNA.
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Figure 3.6A-D. Quantitation by densitometry of EP2 , EP3 , EP4  and FP receptor 
mRNA in myometrium from anterior corpus (MYO), cervix (CX), decidua (DEC) 
and chorion (CHOR) as a ratio to GAPDH. In each blot (see Figure 3.5 for 
representative blots), the highest signal was expressed as unity and the others were 
expressed as a ratio to it. The ratios for 3-5 blots from different animals were then pooled 
and the 4 regions compared by ANC VA, plus Tukey’s multiple comparisons. EP2 mRNA 
expression was significantly greater in the cervix than in the other 3 tissues (p<0.05, 
n=5), E? 3  mRNA was significantly greater in MYO than in the other 3 tissues (p<0.05, 
n=4), EP4 was significantly greater in decidua than in the other tissues (p<0.05, n=3). 
There was no significant difference in EP, or FP (n=3) expression comparing MYO and 
CX.
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3.3 Discussion.
When considering the regulation o f myométrial contractility, most attention is focused on 
factors controlling delivery o f the fetus. However, effective post-partum contraction of 
the uterus is probably equally important from an evolutionary perspective. The processes 
of delivery of the fetus and post-partum contraction are quite different. Delivery o f the 
fetus requires phasic contraction with a relative relaxation o f the lower segment. Post­
partum contraction requires tonic smooth muscle activation o f the whole uterus. 
Therefore, a possible means by which differential regulation o f uterine contraction (i.e. 
pre- and post-delivery o f the fetus) might be studied is by addressing regional variation in 
the control o f contractility.
One reason why these issues have not been fully addressed is the difficulty in obtaining 
specimens of healthy pregnant human myometrium from regions other than the LUS. 
There are some reports o f analysis o f Caesarean hysterectomy specimens and one report 
demonstrated regional variation in oxytocin receptors However, these reports are 
anecdotal and are necessarily limited by the opportunities to obtain healthy tissues. There 
are some studies comparing lower segment strips with biopsies of fundus also obtained at 
the time o f lower segment Caesarean section However, these did not utilize full 
thickness strips o f fundus which introduces a potential for bias in comparing LUS and 
fundus.
At the same time as samples were obtained for Northern analysis, paired samples were 
obtained for contractility studies. It was found that PGE2 contracted myométrial strips 
from the fundus but not the lower segment (These findings are reported in a paper 
where I was first author, but I have not included them in this thesis. Although I directed 
these experiments and devised the experimental protocol, the actual practical work was
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carried out by a colleague and, therefore, I have excluded these data from this thesis.) The 
LUS is formed during pregnancy from the cervix Given the fibrous nature o f the
cervix, it might be expected that the LUS would exhibit a generalized reduced
contractility compared to the fundus. However, its response to PGp2a was virtually 
identical to fundus These observations implied that the lack effect of PGE] on LUS 
was a manifestation o f differences in prostanoid signal transduction.
As discussed in Chapter 1, four receptor sub-types have been identified 
pharmacologically which mediate the effects o f PGE2 EP, and EP3 receptors generally 
stimulate and EP2 and EP, receptors generally inhibit smooth m uscle". I tested the 
hypothesis that the reduced response o f LUS to PGE2 compared with fundus was 
secondary to higher expression o f inhibitory EP receptors and/or lower expression o f 
stimulatory EP receptors in LUS. I found that LUS had more inhibitory EP2 receptor 
mRNA and less contractile EP3 receptor mRNA than the fundus, but similar levels o f EP, 
mRNA (Figure 3.3). This supported the hypothesis that varying receptor populations
explain the different magnitude o f the effects o f PGE2 on LUS and fundus. This
hypothesis was lent further support as the levels o f FP receptor mRNA were similar in 
LUS and fundus (Figure 3.3), also paralleling the response to native PGs Samples o f 
myometrium from the corpus showed similar levels o f EP2 and EP3 mRNA to the fundus 
(Figure 3 .4).
Given that the LUS is formed from the cervix I hypothesized that the cervix might 
exhibit similar quantitative differences in prostanoid receptor mRNA when compared 
with the corpus, EP2, EP3 and EP, receptor mRNA were expressed in myometrium, 
cervix, decidua and chorion (Figure 3.5). There was a characteristic pattern o f expression 
o f the sub-types with the EP2 receptor mRNA most abundant in cervix, EP3 in
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myometrium and EP, in decidua. EP, and FP receptor expression were similar in 
myometrium and cervix (Figure 3.6). Therefore, the pattern o f prostanoid receptor 
mRNA comparing the cervix and corpus paralleled the pattern comparing LUS and 
fundus. I conclude that different proportions o f EP? and EP3 receptors in LUS are likely 
to be due to its cervical origin.
The foregoing assumes that levels o f mRNA parallel the amount o f functional receptors 
in the respective tissues. This assumption is supported by the contractility studies It 
might be further supported by immunocytochemistry or Western blot to confirm 
translation o f mRNA into protein. However, antibodies against the various BP receptor 
sub-types are not yet widely available. The size o f transcripts observed in the present 
study was similar to previous reports of Northern blots from the human. As in previous 
studies in the human, multiple bands were present using the EP3 probe whereas 
discrete bands were observed using the EP2 EP, and FP probes. Furthermore, 
the estimated size o f transcripts was similar to these reports o f Northern analysis o f 
human RNA. Such variation as was observed (less than 20%) may be related to variation 
in un-translated regions o f the gene which has been previously been inferred by the 
discrepancy between the size of the full length cDNA and the size o f transcripts in 
Northern analysis as well as inevitable variation due to experimental error.
These pharmacological differences in LUS and fundus might explain the differential 
regional control o f the uterus before and following delivery o f the fetus. I postulate that 
high levels o f PGE2 from the fetal membranes during labour stimulate EP2 receptors in 
LUS during labour, which would favour selective relaxation o f LUS to allow passage of 
the fetus. Following delivery o f the membranes, PGE2 levels will fall, which would 
favour stimulation o f the EP3 receptor, as its affinity for PGE2 is more than an order of
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magnitude greater than EP2 receptor Furthermore, the activity of other uterotonic 
agents with a purely contractile effect on the LUS, such as PGFaa, would stimulate 
contraction without opposition by E?2-mediated inhibition.
The complex family of prostanoid receptors in decidua and chorion were also of interest. 
Prostaglandins have been postulated to mediate the clinically evident relationship 
between infection and PPROM, but current models invoke an indirect action on the 
membranes, namely, by stimulating uterine activity which then promotes membrane 
rupture The presence of multiple EP receptor sub-types in chorion implies a direct 
effect of PGEz on the fetal membranes. The presence of EP2, EP3 and EP, receptors on 
decidua also suggests that PGE2 acts directly on the decidua. It was interesting that the 
EP, receptor appeared to have much higher levels of expression in the decidua than in 
adjacent tissues. All these receptors are coupled to adenylate cyclase, EP2 and EP, 
positively and EP3 negatively Establishing the effects of cyclic AMP dependent 
protein kinases should shed light on the effects of PGE2 on these tissues.
These data have very clear clinical significance. The high level of EP? expression in the 
cervix (Figure 3.5A) may be important for drug development to induce labour. PGE2 is 
widely employed to prime the cervix The use of PGE2 reduces the incidence of 
prolonged labour, Caesarean and instrumental vaginal delivery However, uterine 
hyper-stimulation (probably EP3 receptor mediated is the dose-limiting side effect of 
vaginal PGE2 PGE2 stimulation of glycosaminoglycan synthesis by cervical 
fibroblasts is mediated by activating adenylate cyclase Given that the EP2 receptor is 
coupled positively to adenylate cyclase "  and EP2 expression is high in the cervix 
(Figures 3.5 and 3.6), it is possible that the effect of PGE2 on the cervix is mediated, at 
least in part, by the EP2 receptor. Selective EP2 agonists (which are currently available ")
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may, therefore, be as effective in priming the cervix as PGE2, but would not be expected 
to cause uterine hyper-stimulation.
There is preliminary evidence to support the above from randomised controlled trials. 
There are two reports that misoprostol is more effective in priming the cervix than PGE? 
without increasing the risk of hyper-stimulation The affinity of PGE2 for the EP3 
receptor is 14-fold greater than the EP2 receptor . However, the affinity of misoprostol 
for the EP3 receptor is less than 4-fold greater than EP2 If the EP2 receptor mediates 
cervical priming, it would be predicted that the greater the relative affinity of a drug for 
the EP2 receptor compared with the EP3 receptor, the safer and more effective it will be in 
priming the cervix. However, this is somewhat at odds with the apparent efficacy of 
sulprostone, a selective EPi and EP3 agonist, in priming the cervix in early pregnancy 
Sulprostone is a potent stimulator of myométrial contractility and it is possible that 
selective agonists of different EP receptor sub-types might prime the cervix by different 
mechanisms of action. The possible role of EP] receptor activation in the control of 
cervical compliance during labour may be inferred by whether the gene is up-regulated or 
down-regulated in labour. This issue is addressed in a later chapter.
The finding that PGFoa contracted both the LUS and fundus and that expression of the 
FP receptor gene was similar in the two regions (Figure 3.3) provide a rational basis for 
the empirical usefulness of 15-methyl-PGF2« in the treatment of PPH refractory to other 
uterotonic agents
PG synthesis inhibitors are currently used in the treatment of pre-term labour but contract 
the fetal ductus arteriosus It has been proposed that selective antagonists of 
prostanoid receptors may be useful in the treatment of pre-term labour and have fewer 
effects on the fetus than COX inhibitors However, the complex pattern of multiple
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EP receptor sub-types and FP receptor expression in key intra-uterine tissues controlling 
parturition (Figure 3.5) may limit the usefulness of a drug acting on a single receptor type 
or sub-type in the treatment of pre-teim labour.
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Chapter 4. The effect of labour and gestational age on expression of prostanoid 
receptor genes in myometrium
It is evident from the human clinical use of exogenous synthetic PGs to induce labour 
that the response to a standard dose of PGEz is highly variable between women, from 
virtually no effect to excessive stimulation of uterine contraction necessitating immediate 
delivery by Caesarean section This observation suggests that the sensitivity of the 
uterus to PGs might be a factor controlling myométrial contractility at term and in labour. 
In the preceding chapter it was established that variation in contractile responses to native 
PGs was paralleled by variation in the expression of prostanoid receptor types and sub- 
types. In the present chapter, I sought to test the hypothesis that variation in the 
expression of prostanoid receptors at term and in labour has a role stimulating 
myométrial contractility in primate parturition. I quantified the expression of prostanoid 
receptor genes in baboon myometrium obtained from 15 animals in the last third of 
pregnancy, five of which were in spontaneous labour. Given that 1 had also previously 
shown that expression of receptor genes varied comparing different regions of the uterus, 
I also determined (a) whether regional variation in prostanoid receptor expression 
persisted in labour and (b) the cellular localization of prostanoid receptor mRNA 
expression.
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4.1 Methods
The general methods were as described in Chapter 2. The animals employed were as 
follows. Ten animals were not in labour and in the last 1/3 of pregnancy at the following 
days gestational age (dGA): 121, 128, 141, 153, 159, 162, 162, 177, 177, 180 (term=180- 
185 days). The cervix was un-effaced and closed in all of these animals. Uterine 
electromyogram leads had been sited in three of these animals going close to term (the 
animals delivered after 170 dGA, term is approximately 185dGA). Analysis of EMG 
traces of the 48 hours preceding surgery revealed that myométrial activity was solely in 
the contractures mode with no contraction activity. No drugs of any form had been 
administered to any of the animals in the two weeks preceding surgery. Caesarean 
hysterectomy was also performed on five animals in spontaneous labour. Of these, four 
had EMG electrodes sited. These animals had a baseline cervical examination at the time 
of their first EMG contraction activity and were re-examined when they had a sustained 
switch from contractures to contractions (>30 minutes). The gestational ages at 
hysterectomy were 164, 184, 191, 193. The cervical dilations for these animals were 6 cm, 
3cm, 3cm and 2cm, respectively (the cervix was closed in all four at the baseline 
examination). In a fifth animal without EMG electrodes. Caesarean section was 
performed at 172dGA and at the time of the procedure it was found that the cervix was 
4cm dilated and fully effaced and a hysterectomy was performed. Samples of 
myometrium were obtained from the fundus and lower segment, flash frozen in liquid 
nitrogen and stored at -80C until use. The lower segment and fundus were defined 
described in Chapter 3.
Primary culture of myométrial cells was established from a sample of uterine fundus 
obtained from an animal in spontaneous labour at 193 days gestational age. In situ
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hybridisation was performed on frozen sections of an animal at 177 days gestation, where 
hysterectomy was performed prior to the onset of labour, from the uterine fundus.
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4.2 Results.
Clear signals of similar molecular weight to the cloned human prostanoid receptors genes 
were detected in myometrium for the EPi, EP], EP], EP4, FP, IP and TP receptors genes 
using riboprobes, both from the lower segment and uterine fundus and from animals in 
labour and not in labour (Figures 4.1 and 4.2). No clear signal above background could 
be detected using an antisense riboprobe for the human DP receptor. All blots were 
stripped and re-probed for each of three housekeeping genes, GAPDH, beta-actin and 
cyclophilin (Figure 4.3).
Densitometric analysis of these signals (expressed as a ratio to beta-actin) demonstrated 
that the level of expression of genes encoding the EP4, FP and TP receptors were similar 
comparing samples obtained from the LUS and the fundus and comparing animals in 
labour and not in labour (Table 4.1).
The only signal that demonstrated a change in the overall level of expression in labour 
was EP] receptor mRNA, which was markedly decreased in myometrium obtained from 
animals in labour. Furthermore, expression of this gene was greater in the lower segment, 
but the magnitude of the difference between the lower segment and fundus diminished in 
association with labour (Figure 4.4 and Table 4.1). The expression of IP receptor mRNA 
also differed comparing lower segment and fundus and the magnitude of the difference 
also significantly differed comparing samples from animals in labour and not in labour 
(Figure 4.4 and Table 4.1). Expression of mRNA encoding the EP| and EP3 receptors was 
also significantly different comparing samples from the lower segment and the fundus, 
but the magnitude of the differences comparing the two regions was not significantly 
affected by labour (Figure 4.4 and Table 4.1). There were no significant changes in the 
expression of prostanoid receptor genes related to gestational age among the animals
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delivered prior to the onset of labour. All but one of the comparisons which were 
statistically significant with beta-actin were also significant when the signal was 
expressed as a ratio to GAPDH or cyclophilin (data not shown). The exception was 
comparison of the IP receptor signal between the lower segment and fundus. This was 
significant at P=0.02 and 0.0004 with beta-actin and cyclophilin, respectively, but the P 
value was 0.15 when related to GAPDH.
In situ hybridisation was attempted for the EP2, EP3, EP4 and IP receptors. Clear signals 
above background were only detected for the EP3 receptor (Figure 4.5A), which is most 
abundantly expressed in myometrium (Chapter 3). Hybridisation of the EP3 riboprobe 
could be prevented by co-incubation with an excess of unlabelled probe (Figure 4.5B). 
The gene encoding the EP3 receptor was expressed in myométrial cells (Figure 4.5C), but 
not in vascular smooth muscle cells of muscular arteries in the uterine wall (Figures 4.5A 
and 4.5D).
Expression of the genes encoding the prostanoid EP2 and EP3 receptors could not be 
detected in cultured baboon myométrial cells. Visual inspection of the cells demonstrated 
that they retained the characteristic spindle shape of smooth muscle cells in culture.
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Figure 4.1. Northern blots of EP receptor genes in baboon myométrial mRNA from 
lower uterine segment (LUS) and fundus (FUN), both not in labour (NIL) and in 
labour (LAB). 2pg each lane loaded in each lane, probed for all four currently 
recognized EP receptor genes. Lanes as follows: EP,: 1-9 = LUS, NIL; 10-14 = LUS, 
LAB; 15-24 = FUN, NIL; 25-29 = FUN, LAB. EPz and EP3 : 1-8 = LUS, NIL, 9-13 = 
LUS, LAB, 15-23 = FUN, NIL; 24-28 = FUN, LAB. EP4:l-9 = LUS, NIL; 10-14 = LUS, 
LAB; 15-23 = FUN, NIL; 24-28 = FUN, LAB.
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Figure 4.2. Northern blots of non-EP prostanoid receptor genes in baboon 
myométrial mRNA from lower uterine segment (LUS) and fundus (FUN), both not 
in labour (NIL) and in labour (LAB). 2pg each lane, probed for the IP, FP and TP
receptor genes. Lanes as follows: IP: 1-9 = LUS, NIL; 10-14 = LUS, LAB; 15-23 = 
FUN, NIL; 24-28 = FUN, LAB. FP and TP: 1-9 = LUS, NIL; 10-14 = LUS, LAB; 15-24 
= FUN, NIL; 25-29 = FUN, LAB.
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Figure 4.3. Northern blots of housekeeping genes in baboon myométrial mRNA 
from lower uterine segment (LUS) and fundus (FUN), both not in labour (NIL) and 
in labour (LAB). 2pg each lane consecutively probed and stripped for the GAPDH, beta- 
actin and cyclophilin genes. Lanes as follows: 1-9 = LUS, NIL; 10-14 = LUS, LAB; 15- 
24 = FUN, NIL; 25-29 = FUN, LAB.
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Figure 4.4. Densitometric quantitation of prostanoid receptor signals (as a ratio to 
beta-actin signal) for prostanoid receptor types in lower uterine segment (LUS) and 
fundus (FUN) from animals both not in labour (white bars) and in labour (shaded 
bars). A, EP] receptor B. EP] receptor C. EP] receptor and D. IP receptor. Significant 
differences between groups, compared with repeated measures ANOVA: effect of labour, 
EP] only; uterine site, EP], EP], EP] and IP; interaetion between uterine site and labour, 
EP] and IP only. For details of statistical analysis, see table 4.1.
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Figure 4.5. In situ hybridisation of EP] receptor riboprobe of section from uterine 
fundus, obtained from animal not in labour at 177 days gestation. A. Low power, 
dark field, probe without competitor. B. Low power, dark field, probe plus unlabelled 
competitor. C. Medium power of myométrial smooth muscle cells. D. Medium power 
vascular smooth muscle cells from muscular artery within uterine wall.
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Figure 4.6 Expression of EP2 and EP3 receptor genes in fresh and cultured 
myometrium from uterine fundus of animal in term labour. Lane 0, flash frozen 
intact fundus, lanes 1-4 first four passages of primary culture of myometrium from same 
animal. 0.5 pg RNA loaded in each lane.
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4.3 Discussion.
There are a number of lines of evidence in a range of species that have indicated a key 
role for PGs in the control of parturition, and these were reviewed in Chapter 1 . Much of 
the research on the potential role of PGs in the initiation and promotion of labour has 
focused on factors determining the concentration of endogenous PGs in intra-uterine 
tissues, in particular the relative balance of the expression and activity of PG synthetic 
enzymes (COX-1 and COX-2) and PGDH, which converts PGs to inactive metabolites 
A number of other studies have looked at signal transduction aspects of myométrial 
smooth muscle which may affect the response of the uterus to PGs, such as expression of 
G-proteins and genes encoding gap junctions However, there has been much less 
research on the role of variation in the expression of prostanoid receptor types and sub- 
types in the control of myométrial contractility in the human and non-human primate.
The most striking observation of the present study was that labour was associated with a 
much lower level of expression of the inhibitory prostanoid EP2 receptor and this was 
observed both in the fundus and lower segment. Studies of isolated strips of human 
myometrium have demonstrated a profound inhibitory effect of EP% agonists on 
contractility and a profound excitatory effect of EP3 receptor activation Reduced 
expression of EP2 receptors would be anticipated to increase the stimulatory effect of a 
given concentration of PGE2 on the myometrium acting through EPi and EP3 receptors 
and, therefore, promote the process of parturition. I hypothesize, therefore, that reduced 
expression of the inhibitory EP? receptor in primate myometrium may have a key role in 
promoting myométrial contraction during labour. If confirmed in the human, this 
suggests that an EP2 receptor antagonist might have a role in the induction of labour and 
that an EP? receptor agonist may have a role in the treatment or prophylaxis of preterm
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labour, although the effect of such a drug may be diminished in active labour due to loss 
ofEP] receptor expression.
I confinned the previous observation (Chapter 3) of regional differences in EP] and EP3 
receptor gene expression comparing lower segment and fundus and that these differences 
were maintained in labour. Interestingly, the magnitude of the difference in EP2 receptor 
gene expression between the lower segment and fundus was significantly diminished by 
labour, although a difference persisted.
By optimizing techniques, principally the use of riboprobes, I could also detect EP|, TP 
and IP receptor gene expression using Northern analysis, whereas these genes could not 
be detected using the initial methodologies outlined in Chapter 3. These studies 
demonstrated regional variation in both the EPi and IP receptor genes. In the case of the 
EP| receptor gene, expression was greater in the fundus than the lower segment, but 
labour had no statistically significant effect on either the absolute level of expression or 
the difference between the two regions. In the case of the IP receptor gene, expression 
was lower in the lower segment before labour, but not in tissue obtained during labour. 
The higher level of expression of the excitatory EP| is consistent with the previous 
observation that strips of myometrium from the fundus exhibited a greater contractile 
response to PGE2 than strips from the lower segment The greater level of expression 
of the inhibitory IP receptor in the lower segment during labour suggests that PGI2 may 
inhibit myométrial contractility in the lower segment during labour, but this issue 
requires further study.
Relating the current observations to previous studies there are interesting parallels and 
differences. Reduced expression of EP2 receptor mRNA in myometrium in association 
with labour (or advancing gestational age) has now been demonstrated in the baboon
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(present study), rat and human but not in sheep This species difference in 
genetic expression is paralleled by functional differences in response of myométrial 
strips, since both human and baboon myometrium relax in response to EP2 receptor 
agonists, whereas these drugs are without effect in ovine myometrium 
The lack of an effect of labour on expression of the FP receptor gene differs from studies 
using human LUS which demonstrated increased FP receptor mRNA in biopsies taken 
from women in labour at the time of Caesarean section, as well as animal studies in the 
rat and sheep The contractile response to PGFia and expression of FP receptor 
mRNA is the same in myométrial strips from the lower segment and fundus of baboons 
I interpreted this observation as possibly indicating a major role for the FP receptor in 
post-partum contraction of the uterus, consistent with the efficacy of FP agonists in the 
management of refractory atonic PPH It is possible, therefore, that expression of FP 
receptor mRNA could increase in the final stages of labour, and that the time of sampling 
of myometrium with respect to the total duration of labour, may explain this difference. 
The only receptor gene that could reliably be localized using in situ hybridisation was the 
EP3 receptor, which is the prostanoid receptor most abundantly expressed in myometrium 
(Chapter 3). As expected from functional studies this gene was noted to be highly 
expressed in myométrial cells (Figures 5A and 5C). Interestingly, the gene did not appear 
to be expressed in the smooth muscle of small uterine arteries (Figures 5A and 5D). This 
observation suggests that there may be differential control of myométrial and vascular 
smooth muscle in the uterus. The blood vessels supplying the uterine muscle would be 
expected to be dilated most when the uterus was most metabolically active, i.e. during 
labour. Therefore, uterine vascular smooth muscle should be in a relaxed state when 
myométrial smooth muscle is in its most active state. On the basis of the in situ
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hybridisation findings, differential regulation of myométrial and vascular smooth muscle 
may be effected by differential expression of prostanoid receptor genes.
Further studies should attempt to confirm that variation in levels of gene expression in the 
present study are reflected in variation in the number of functional receptors. 
Furthermore, elucidation of the factors which control EP2 receptor gene expression in 
primate myometrium may shed light on the control of primate myométrial contractility at 
the molecular level. The loss of expression of the prostanoid EP2 and EP3 receptor genes 
in cultured baboon myométrial cells was disappointing as it was hoped that the factors 
controlling expression of these genes might have been studied in this model.
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Chapter 5. The effect of labour and gestational age on expression of prostanoid 
receptor genes in cervix
Prostaglandins (PGs) are known to have a key role in the control of cervical compliance 
in human pregnancy Appreciation of the physiological role of PGs led to clinical trials 
of exogenous synthetic PGE2 as a means of improving cervical compliance prior to 
induction of labour. A large number of randomized controlled trials have demonstrated 
that PGE2 is an effective agent in priming the cervix and that its use prior to induction of 
labour reduces the risk of failed induction and operative delivery The principal side 
effect of PGE2 in this context is uterine hyper-stimulation. Although PGE2 reduces the 
overall risk of Caesarean section, the risk is increased in the interval immediately 
following insertion of PG due to occasional induction of hypertonic uterine activity^*'.
In Chapter 3, I demonstrated that the cervix exhibited much greater levels of expression 
of the adenylate cyclase coupled EP2 receptor than myometrium, decidua or chorion I 
hypothesized that the EP2 receptor may mediate the clinically important effects of PGE? 
on cervical compliance. Characteristically, expression of genes encoding receptors for 
hormones that have a stimulatory role in parturition is increased in the given tissue in 
association with labour This suggests that if any of the prostanoid receptors had a 
major role in mediating the changes in cervical compliance associated with labour, that 
there would be an increase in the expression of the gene encoding the receptor. 
Conversely, if any receptor mediated an inhibitory effect on these changes, it suggests 
that the expression of the gene may be decreased in labour. In the this chapter I report 
quantitative Northern analysis of all the currently recognized G-protein coupled 
prostanoid receptor genes in the cervix obtained from pregnant baboons by total
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Caesarean hysterectomy, comparing animals in labour and not in labour at the time of 
surgery.
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5.1 Methods.
The same animals described in Chapter 4 were employed and the general methods were 
as outlined in Chapter 2.
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5.2 Results.
Clear signals of similar molecular weight to the human prostanoid EPi, EPi, EP3, EP4, 
FP, IP and TP receptors genes were detected using Northern analysis of cervical mRNA 
(Figures 5.1 and 5.2). Multiple transcripts were observed for the EP3, IP and TP receptor 
genes. No clear signal above background could be detected using an anti sense riboprobe 
for the human DP receptor.
There was a significant increase in the level of expression of the EP| receptor with 
advancing gestational age (Figure 5.3 and Table 5.1). There were no gestational age- 
related changes in the level of expression of any of the other receptor genes (Table 5.1). 
There were marked and highly significantly lower levels of expression of the EPz, FP and 
TP receptor genes in samples obtained from animals in labour compared with those not in 
labour (Figure 5.4 and Table 5.2). There was no significant difference in the levels of 
expression of the genes encoding the EPi, EP3, EP4 or IP receptors comparing animals in 
labour and not in labour (Table 5.2).
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Figure 5.1. Northern blot of prostanoid EP receptor gene sub-types in baboon 
cervix. A. E?i receptor, B. EP] receptor, C. EP3 receptor, D. EP4 receptor. In each case 
the membrane was re-probed for each of the three housekeeping genes, GAPDH, beta 
actin and cyelophilin. The estimated molecular weight of transcripts is given in kilobases 
(kB) from interpolation of markers as described in Methods. The same quantity of mRNA 
(either 2 or 4 pg) was loaded in each lane in a given blot. A. Lanes 1-7 not in labour 
(NIL), lanes 9-13 in labour (LAB). B-D. Lanes 1-8 NIL, lanes 10-14 LAB.
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Figure 5.2. Northern blot of non-EP prostanoid receptor gene sub-types in baboon 
cervix. A, FP receptor, B. IP receptor, C. TP receptor. In each case the membrane was 
re-probed for each of the three housekeeping genes, GAPDH, beta actin and cyelophilin. 
The estimated molecular weight of transcripts is given in kilobases (kB) from 
interpolation of markers as described in Methods. The same quantity of mRNA (either 2 
or 4 pg) was loaded in each lane in a given blot. All blots lanes 1-7 not in labour, lanes 9- 
13 in labour.
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Figure 5.3. Expression of EPi receptor mRNA in cervix (n=7) with advancing days 
of gestational age (dGA). Simple linear regression of EPi receptor gene expression 
(relative to beta-actin, expressed as densitometric ratio) related to gestational age in 
animals not in labour (n=7). See Table 5.1 for statistical analysis.
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Figure 5.4. Expression of prostanoid receptor genes relative to beta-actin in cervix 
of animals in labour (LAB) and not in labour (NIL). A. EP2 receptor gene (NIL n=8 , 
LAB n=5), B. FP receptor gene (NIL n=7, LAB n=5), C TP receptor gene (NIL n=7, 
LAB n=5). See Table 5.2 for statistical analysis. Columns are means and bars are SEM.
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Table 5.1. Relationship between gestational age and cervical prostanoid receptor 
gene expression as a ratio of three housekeeping genes.
GAPDH Beta-actin Cyelophilin
„2   2 p= r
EP, (1 1 = 7 ) 0.04 0.61 0.007 0.79 0 . 0 1 0.76
EPz (n=8 ) 0.08 0.91 0.03 0.59
EP] (n=8 ) 0.69 0.94 0.80
EP4 (n=8 ) 0.56 0.69 0.91
IP (n=7) 0.15 0.27 0.53
FP (n=7) 0 . 2 2 0.91 0.32
TP (n=7) 0.18 0.85 0.28
The p value is given for simple linear regression, where the ratio of the gene of interest to 
the given housekeeping gene is the dependent variable and gestational age is the 
independent variable. Virtually identical results were obtained using Spearman’s rho. 
None of the animals were in labour at the time of delivery. The relationship between EPi 
gene expression and gestational age was positive (Figure 5.3).
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5.3 Discussion.
Administration of PGEi is well established as a method for preparing the cervix prior to 
induction of labour The identification of multiple sub-types of EP receptor 
suggested that there may be a role for selective agonists of EP receptor sub-types in 
cervical priming. In Chapter 3, I compared the level of expression of EP and non-EP 
prostanoid receptors in the baboon and had found that there were high levels of 
expression of the adenylate cyclase-coupled EP] receptor in the cervix. I hypothesized 
that this may be the receptor which mediates the clinically important effects of PGE]. A 
significant weakness in the hypothesis was the efficacy of sulprostone in priming the 
cervix since the drug is virtually devoid of EP] receptor agonist activity 
In this chapter, I report that expression of the gene encoding the EP] receptor was 
actually lower in the cervix of animals that were in labour compared with animals not in 
labour (Table 5.2 and Figure 5.4A). This suggests that the EP] receptor does not mediate 
the effects of PGE] on the cervix which promote dilatation. Consequently, I now 
hypothesize that the EP] receptor might inhibit changes in the cervix which promote 
dilatation, that loss of EP] receptor expression may be a factor which promotes cervical 
dilatation, and that the effects of PGE] on the cervix which promote dilatation are 
mediated through a receptor other than the EP] receptor. The EP, receptor is a candidate 
since its level of expression increased with advancing gestational age (Figure 5.3). 
However, sulprostone, 16,16 dimethyl-PGE, and misoprostol are all effective agents for 
priming the ceiwix and all three drugs are agonists of the EP] receptor whereas 
misoprostol is a weak EP, receptor agonist It seems most likely, therefore, that the EP] 
receptor mediates the effects of PGE] which promote dilatation of the cervix. I propose 
that a marked reduction in the expression of the inhibitory EP] receptor during labour
- 94 -
results in an uncovering of EP] receptor-mediated effects, promoting changes in cervical
compliance and, consequently, cervical dilatation. This hypothesis is supported by the
observation that the EP] and EP] receptors mediate opposing effects on adenylate cyclase 
11
A âirther unexpected finding in the present study ’was the lower level of expression of the 
genes encoding the FP and TP receptors in the cervix obtained from animals in labour 
(Figure 5.4B and C, Table 5.2). PGF]a has been employed clinically as a means of 
inducing labour, but it requires an approximately 10-fold greater dose than PGE] for a 
given therapeutic effect and this is associated which a much greater level of systemic 
adverse effects There are very little data on the possible role of the TP receptor in the 
péripartum control of the cervix. But the current study suggests that a decrease in FP and 
TP receptor mediated effects may stimulate changes in the cervix which promote cervical 
dilatation.
Activation of the prostanoid EP] receptor usually stimulates adenylate cyclase 
whereas both FP and TP receptor activation generally stimulate calcium influx In 
many tissues, including myometrium, activation of these receptors results in opposing 
effects It seems paradoxical, therefore, that receptors which mediate opposing effects 
might exhibit parallel changes in their level of expression in association with labour. The 
physiological significance of an increase or decrease in the overall level of expression of 
a given gene in the whole tissue depends on the cell type(s) that express the gene, the 
second messenger that the receptor is coupled to within the given cell type, the effect of 
activation of the given second messenger on the activity of the cell, and the role of that 
cell type in promoting cervical dilatation. 1 hypothesize that the parallel levels of 
expression of the EP], FP and TP receptor genes in labour might reflect changes in the
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level of expression of these genes in different cells types with different roles in promoting 
ceiwical dilatation. I attempted to identify the cell types expressing prostanoid receptor 
genes in the cervix using in situ hybridization, but could not reliably detect signals above 
background due to diffuse low levels of expression.
The foregoing assumes that there is a correlation between expression of the gene 
encoding the receptor and the amount of functional receptor present. This assumption is 
supported by the data presented in Chapter 3 which demonstrated parallels between 
regional variation in the contractile response to PGs and the expression of genes 
encoding prostanoid receptor genes in baboon myometrium. Ideally, however, the 
findings of our present study should be confirmed by other techniques such as 
radioligand binding or Western blot analysis. However, radioligand binding has 
limitations as a technique to characterize prostanoid receptor populations due to the lack 
of truly selective ligands a problem underlined by studies using cells expressing 
recombinant prostanoid receptors which have demonstrated that many ligands which are 
supposed to be highly selective for a given receptor or receptor sub-type bind extensively 
to other receptors . The use of Western blot analysis is limited by the fact that 
antibodies for all the receptor types and sub-types are not yet widely available. The size 
of bands observed were similar to those observed in myometrium (Chapter 4) which were 
themselves similar to previous studies using human tissues.
Assuming that the current findings can be extrapolated to the human, these data have 
implications for drug development. First, it has previously been demonstrated that the 
major effects of PGE] on human myometrium are mediated through the EP] receptor 
If, as seems likely on the basis of our studies in the baboon, the EP] receptor is also the 
major effector of PGE] in the cervix, it raises the possibility that an EP] receptor
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antagonist might be an effective uterine tocolytic, which would also have an inhibitory 
effect on cervical compliance. Such a drug would have the advantage over COX 
inhibitors that it would not attenuate the inhibitory effects of EP? receptor activation It 
would also not be expected to contract the fetal ductus arteriosus, the dose limiting side 
effect of indomethacin since this is mediated by loss of PGE] acting through the EP4 
receptor The present observations also suggest a possible role for an EP] receptor 
antagonist in the induction of labour. This is supported by the finding reported in Chapter 
4 that expression of the EP] receptor gene is also reduced in myometrium in association 
with labour. Similarly, in human myometrium, decreased EP] receptor gene expression 
has been described with advancing gestational age Finally, the previous demonstration 
of a profound inhibitory effect of EP] receptor activation on myométrial contractility 
and the current proposal that the same receptor might exert inhibitory effects on cervical 
dilatation suggest that an EP] agonist may have a role in the management of preterm 
labour.
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Cliapter 6 . The effect of labour and gestational age on expression of prostanoid 
receptor genes in decidua and chorion
The fetal membranes and decidua are thought to have a key role in the control of 
parturition in the human and non-human primate. In analyses of cases of preterm labour, 
approximately 30-40% of births are associated with PPROM Furthermore, the 
membranes are thought to have an important paracrine role in the control of myométrial 
contractility, both in spontaneous term labour and in preterm labour secondary to 
intra-uterine infection The decidua is also thought to have an important paracrine role 
in the control of the myometrium being both a source of PGs and other important 
regulators, such as oxytocin
The amnion is thought to be a critical site of PG synthesis in relation to parturition in a 
number of species, including the human The chorion also expresses PG synthetic 
enzymes, although a key role has been postulated for the chorion by acting as a barrier 
for diffusion of PGs from the amnion to the myometrium due to high levels of expression 
of PG dehydrogenase (PGDH): expression of PGDH falls in association with labour 
implicating a role for this barrier function in maintaining uterine quiescence. 
CuiTently, most models for the role of PGs in the fetal membranes and decidua consider 
the membranes as sources of either PG biosynthesis or sites of PG catabolism 
Furthermore, any effects of PGs from the fetal membranes and decidua are thought to be 
paracrine, mediated through changes in myométrial contraction However, in Chapter
3 ,1 demonstrated a complex pattern of expression of genes encoding prostanoid receptors 
in the chorion and decidua of pregnant baboons which suggests that PGs synthesized in 
the membranes and decidua may also have autocrine effects.
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I hypothesize that PGs may have direct effects on decidua and chorion which in turn may 
have a role in the initiation of parturition in primates. Characteristically, genes encoding 
signal transduction proteins of systems which have a role in labour are expressed at 
higher levels in tissues (both myométrial and non-myometrial) from animals which are in 
labour compared with animals not in labour, and there are many examples of such 
phenomena 25;ii3;i39;2i4 initial test of the hypothesis that direct effect of PGs on
decidua and chorion may have a role in the initiation of parturition, I sought to determine 
whether expression of prostanoid receptor genes varied according to gestational age and 
whether the animal was in labour or not in labour at the time the tissue was obtained.
- 9 9 -
6 . 1  Methods
The same animals described in Chapter 4 were employed and the general methods were 
as outlined in Chapter 2.
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6.2 Results.
Clear signals of similar molecular weight to the cloned human prostanoid receptors genes 
were detected in decidua to probes for the EP,, EP], EP], EP4, FP, IP receptors (Figures
6.1 and 6.2). No clear signal above background could be detected using an antisense 
riboprobe for the human DP receptor. Clear signals of similar molecular weight to the 
cloned human prostanoid receptors genes were detected in chorion to probes for the EP,, 
EP], EP], EP4, and IP receptors (Figures 6.3 and 6.4). No clear signal above background 
could be detected using antisense riboprobes for the human DP or FP receptor genes. 
Weak signals could be detected in both tissues to a TP receptor probe (Figures 6.2 and 
6.4). However, the signal to noise ratio for the TP receptor gene transcript was too low in 
both tissues for meaningful quantitative analysis.
There was a statistically significant negative correlation between the level of expression 
of the EP, and FP receptor genes in decidua and EP4 expression in the chorion and the 
gestational age at the time of hysterectomy among animals which were not in labour 
(Figure 6.5). There were no other significant relationships between gene expression and 
gestational age in either tissue (Table 6.1). Results of similar statistical significance were 
obtained when correlation was tested using Spearman’s rho (data not shown).
There was a significantly lower level of expression of the EP] receptor gene in decidua 
from animals in labour (Figure 6 .6 A) but a higher level of expression of the IP receptor 
gene in decidua (Figure 6 .6 B) and chorion (Figure 6 .6 C) from animals In labour. There 
were no other significant differences in the level of expression of the other prostanoid 
receptor genes in either tissue comparing samples from animals in labour and not in 
labour (Table 6.1).
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For the signals which were observed to vary with gestational age (EP, and FP in decidua 
and EP4 in chorion) a further comparison was made of tissues obtained from animals in 
labour with animals not in labour, where the comparison was adjusted for gestational age 
using analysis of covariance. In ail three cases there was still no significant change in 
levels of expression associated with labour after adjusting for the effect of gestational age 
(EPi decidua, P= 0.65; FP decidua, P= 0.95; EP4 chorion, P= 0.65).
All the above comparisons were made expressing the level of the given gene as a ratio to 
beta-actin. Significant results were also observed when levels were expressed relative to 
one of the other housekeeping genes, with one exception. There was a negative 
correlation of borderline statistical significance between gestational age and EPi 
expression in chorion relative to beta-actin (P=0.05). This association was not statistically 
significant when the EP, signal was related either to GAPDH (P=0.87) or cyelophilin 
(P=0 . 11).
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Figure 6.1. Northern blot of EP receptor mRNA in decidua. Either 2 or 4 pg each 
lane, same quantity loaded in each lane in given blot) probed for A. E?i receptor gene, B. 
E?2 receptor gene, C. EP3 receptor gene, D. EP4 receptor gene. All membranes 
consecutively stripped and re-probed for three housekeeping genes. Estimate size of 
transcripts estimated in kilobases (kB).
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Figure 6.2. Northern blot of non-EP prostanoid receptor mRNA in decidua. Either 2 
or 4\xg each lane, same quantity loaded in each lane in given blot, probed for A. FP 
receptor gene, B. IP receptor gene, C. TP receptor gene. All membranes consecutively 
stripped and re-probed for three housekeeping genes. Estimate size of transcripts 
estimated in kilobases (kB).
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Figure 6.3. Northern blot of EP receptor mRNA in chorion. Either 2 or 4 |ig each 
lane, same quantity loaded in each lane in given blot, probed for A. E?i receptor gene, B. 
E? 2  receptor gene, C. EP] receptor gene, D. EP4 receptor gene. All membranes 
consecutively stripped and re-probed for three housekeeping genes. Estimate size of 
transcripts estimated in kilobases (kB).
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Figure 6.4. Northern blot of non-EP prostanoid receptor mRNA in chorion. Either 2 
or 4 |ig each lane, same quantity loaded in each lane in given blot, probed for A. IP 
receptor gene, and B. TP receptor gene. All membranes consecutively stripped and re­
probed for three housekeeping genes. Estimate size of transcripts estimated in kilobases 
(kB).
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Figure 6.5. Prostanoid receptor gene expression related to gestational age among 
animals not in labour in decidua and chorion. A. EPi receptor gene in decidua (r  ^ = 
0.7, P=0.002), B. FP receptor gene in decidua (r  ^ = 0.7, P=0.008), and C. EP4 receptor 
gene in chorion (r  ^ == 0.7, P=0.01). Signals quantified using densitometry and expressed 
as a ratio (arbitrary units) to signal for beta-actin.
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Figure 6.6. Variation in expression of prostanoid receptor genes (expressed as ratio 
to beta-actin) in relation to labour. A, EP2 receptor gene in decidua, B. IP receptor 
gene in decidua, C. IP receptor gene in chorion. NIL = not in labour (n=8-10), LAB = 
labour (n=5). Statistical comparison by Student’s t test. Columns are means, bars are 
SEM.
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6.3 Discussion.
Studies on the control of parturition have naturally tended to focus on the myometrium, 
since uterine contraction is clearly central to the process of expulsion of the fetus. 
However, 30-40% of preterm births follow PPROM The relative ease of study of the 
effect of dings and hormones on myometrium has probably increased the focus on this 
tissue. However, given the direct contribution of membrane integrity to the process of 
preterm delivery, and the secondary paracrine effects of choriodecidual activation on 
myométrial contractility it is possible that drugs that directly target the membranes and 
decidua may be effective in the treatment or prophylaxis of preterm labour. Indeed, it is 
likely, that the apparent efficacy of indomethacin in delaying delivery may be due in a 
major part to its effects on PG synthesis in the fetal membranes and decidua. 
Consequently, it is important to understand the regulation of function of the fetal 
membranes and decidua. In Chapter 3, I demonstrated that there is a complex pattern of 
expression of prostanoid receptor genes in baboon chorion and decidua. The genes 
expressed in chorion and decidua were also expressed in myometrium and cervix. 
Although receptors are often broadly described as inhibitory or stimulatory, these 
generalizations usually refer to the effects of receptor activation on smooth muscle. 
However, it does not follow that a receptor which usually mediates an inhibitory response 
on smooth muscle will always tend to inhibit non-smooth muscle tissues. A good 
example of this of the effect of beta- 2  adrenoceptor agonists on different excitable 
tissues; these drugs typically inhibit myométrial and vascular smooth muscle contractility 
whereas they increase myocardial contractility The factors determining the effect 
of an agonist on a tissue include the cell types in the tissue, the receptors expressed on the 
different cell types, the second messenger to which the receptor is coupled, the nature of 
the coupling between the receptor and second messenger, the effect of activation (or
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inhibition) of the second messenger on the activity of the cell type, and the role of the 
given cell type in the regulation of the tissue. Clearly, it does not follow that an agonist 
which inhibits myométrial contractility will also inhibit the labour-promoting activities of 
all other intra-uterine tissues where the given signal transduction system is active. A good 
recent example of this are nitric oxide donors which inhibit myométrial contractility 
but actually promote cervical dilatation
The complex pattern of expression of prostanoid receptors in myometrium (Chapter 4) 
and the widespread clinical use of prostanoids and their synthesis inhibitors in the 
therapeutic control of myométrial contractility suggest possible roles for drugs with 
selective activity at prostanoid receptors in the clinical manipulation of the uterus in term 
and preterm labour. The demonstration that the genes encoding these receptors are 
expressed in the chorion and decidua suggested that these receptors might have a role in 
the control of these key tissues in labour. As stated above, it cannot be safely assumed 
that receptors which typically inhibit myometrium would also exert inhibitory effects on 
the chorion and decidua. In order to understand the effects of drugs with selective activity 
on prostanoid receptors in the control of labour, their effects on non-myometrial tissues 
also need to be resolved. One way of drawing inferences about the effect of a given 
system in the control of parturition is by studying the expression of its component parts in 
pregnancy and during labour. This approach has demonstrated (for example) increased 
expression in labour of genes encoding gap junctions in myometrium COX-2 in
amnion and nitric oxide synthase in cervix There is evidence in each of these cases 
that the increased expression of the given gene is involved in the control of labour. 
Furthermore, the realization of the profound increase in COX-2 gene expression has led 
to the successful exploration of selective inhibitors of this enzyme in the management of 
preterm labour and the recognition of the possible role of nitric oxide in the control of
- I l l  -
the cervix led to successful trials of NO donors to prime the cervix clinically *’^4;224 
Therefore, as an initial investigation of the possible role of prostanoid receptors in the 
control of the primate chorion and decidua, I sought to determine whether expression of 
these genes varied in these tissues with advancing gestational age or in association with 
spontaneous term labour.
Four patterns of change in expression of prostanoid receptor genes in the decidua and 
chorion were observed. The first pattern observed was a decrease in expression of genes 
encoding receptors which are positively coupled to the phosphatidyl inositol cascade (EPi 
and FP) in decidua with advancing gestational age (Figure 6.5A and B). The parallel 
decrease in these receptors with advancing gestational age suggests that a prostanoid 
mediated response acting through the phosphatidyl inositol cascade might inhibit changes 
in the decidua which promote labour. However, activation of these receptors increases 
myométrial contractility and, in the cervix, EPi receptor gene expression increases with 
advancing gestational age (Chapter 5). Therefore, these data suggest that EPi and FP 
receptor-mediated effects may promote parturition in some tissues and inhibit the process 
in others.
The second pattern that emerged was a decrease in the expression of a gene which 
encodes a receptor (EP4) which is positively coupled to adenylate cyclase in chorion with 
advancing gestational age (Figure 6.5C). This suggests that an adenylate cyclase 
mediated effect may inhibit changes in chorion which promote parturition. This parallels
myometrium, where adenylate cyclase coupled receptors inhibit myométrial contractility
86:220
The third pattern was a lower level of expression of the gene encoding an adenylate 
cyclase coupled receptor (EP2) in decidua obtained from animals in spontaneous labour 
(Figure 6 .6 A). This suggests that an adenylate cyclase-mediated effect may inhibit
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parturition in decidua in cells expressing the EP2 receptor. This parallels decreased EP2 
receptor expression in myometrium and cervix in labour (Chapters 4 and 5). I 
hypothesize that reduced expression of this inhibitory receptor may have a key role in 
promoting parturition in the primate. The absence of any change in expression of the EP? 
receptor in chorion suggests differential transcriptional control in maternal and fetal intra­
uterine tissues.
The fourth pattern, observed in both the decidua and chorion, was an increase in the 
expression of a gene encoding an adenylate cyclase coupled receptor (IP) and this was 
particularly marked in the chorion (Figure 6 .6 B and C). This suggests that adenylate 
cyclase activation might promote parturition in cells expressing the IP receptor in these 
tissues. It was interesting to observe two adenylate cyclase coupled prostanoid receptors 
(EP2 and IP) vary in opposite directions in decidua in association with labour. This 
underlines the potential for the same second messenger system to mediate different 
effects in different cells types and this presumably has its basis in differential effects of 
protein kinase A in different cell types. Activation of the IP receptor in myometrium 
inhibits myométrial contractility and this observation, like decreased EPi and FP 
expression in decidua with advancing gestational age, suggests dissociation of roles of 
receptors in choriodecidua compared with other key tissues. The present findings suggest 
that extreme caution should be applied in any studies seeking to exploit the IP receptor 
pathway as a means of uterine tocolysis, since any inhibitoiy, therapeutic effect on 
myometrium may be undermined by effects on the choriodecidua.
Cellular localization of expression of these receptors may allow some inferences to be 
drawn regarding their physiological roles. I attempted in situ hybridisation for the EP2, 
EP], EP4 and IP receptor genes. However, reliable signals were not obtained due to low 
levels of expression and high levels of non-specific binding. Other techniques to localize
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signal have certain limitations. Receptor autoradiography is limited by the extensive cross 
reactivity of available ligands , and immunocytochemistry is limited by the lack of well 
characterized and specific antibodies.
There are relatively few data on prostanoid receptors in the fetal membranes and decidua. 
A previous study failed to demonstrate variation in either EP2 or EP4 receptor gene 
expression in labour in ovine endometrium in association with labour However, 
species differences between the sheep and baboon have previously been demonstrated for 
EP2 receptor mediated effects on myometrium Furthermore, myométrial EP]
receptor gene expression decreases in both the baboon and human in labour or at 
term, whereas it is unchanged in sheep These findings, taken together, suggest 
significant species difference between primates and sheep in terms of uterine prostanoid 
receptors and underline the importance of studies in non-human primates.
A number of studies have postulated a role for prostanoid receptors in the endometrium 
in association with implantation An important role for PGs in this context is 
supported by the failure of implantation and decidualisation in mice which are null 
mutant for the COX-2 gene and this may be due to the absence of PGE Other 
studies have demonstrated expression of the EP| receptor on amnion WISH cells. 
Expression of the EPi receptor in these tissues is stimulated by CRH interleukin-1 beta 
interleukin-4 and tumour necrosis factor-alpha Interestingly, the effect of CRH 
appeared to be mediated by PGEi suggesting the possibility of a feedback loop. 
However, the data presented in this chapter are the first, to my knowledge, to support the 
concept that a changing pattern of prostanoid receptor expression may have a role in 
choriodecidual activation in labour.
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Chapter 7. The effect of corticosteroids, gestational age and birth on expression of 
EP receptor genes in ductus arteriosus
The ductus arteriosus is a shunt blood vessel of fetal life. It diverts deoxygenated blood 
from the main pulmonary artery to the descending aorta. Following birth, the direction of 
flow across the ductus reverses and the vessel ultimately closes in the first 1 - 2  days of 
neonatal life.
Patency of the ductus in fetal life is an active state and is maintained by the tonic dilator 
effect of high circulating concentrations of PGE], which relaxes ductal smooth muscle 
through the adenylate cyclase coupled EP4 receptor Cyclic adenosine monophosphate 
(cAMP) inhibits the intrinsically high sensitivity of ductal smooth muscle to the 
[Ca“"^ ]i'®'. Following birth, circulating concentrations of PGE? fall and loss of PGE2- 
mediated activation of adenylate cyclase uncovers the vessel’s intrinsically high 
sensitivity to [Ca^’*’]j Furthermore, the physiological increase in arterial oxygen tension 
which follows birth depolarises ductal smooth muscle by closing oxygen sensitive 
delayed rectifier potassium channels resulting in intracellular calcium influx in ductal 
smooth muscle cells The central role of the prostanoid EP4 receptor in the control
of ductal patency has been underlined by the observed failure of normal closure of the 
vessel following birth in EP4 receptor gene null mutant mice However, the paradox 
that the absence of a gene encoding an inhibitory receptor results in failure of ductal 
contraction following birth remains to be satisfactorily explained.
The sensitivity of the ductus arteriosus to the dilator effect of PGE] is decreased by 
antenatal exposure to corticosteroids by advancing gestational age and following 
birth However, these factors also affect the sensitivity of the vessel to a range of other 
vaso-active agents [see for review], and it is not clear whether the altered response to 
PGE] represents a specific change in ductal PG signal transduction. Furthermore,
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functional studies also suggest that the ductus expresses a contractile EP receptor, 
probably EP3 It is not clear whether an alteration in the balance of contractile and 
dilator EP receptors has a physiological role in the ontogenic and perinatal control of the 
vessel.
The ductus arteriosus, like myometrium, is profoundly under the control of PGs and most 
current models of ductal control -  like models of parturition - focus on the potential role 
of changes in PG concentration. In the preceding chapters, I demonstrated that advancing 
gestational age and labour are associated with changes in the relative expression of 
prostanoid receptor genes in key intra-uterine tissues. The aim of this part of my study 
was to determine whether this was also true of the fetal preparation for birth. Therefore, I 
sought to test the hypothesis that loss of EP4 receptor gene expression might have a role 
in mediating ductal closure following birth. I also predicted that the ratio of EP4 to EP3 
gene expression might change following birth, due to decreased EP4 expression, 
increased EP3 expression or both. I also sought to deteimine the effect of antenatal 
corticosteroids and advancing gestational age on the expression of these genes and to 
determine whether EP4 receptor mRNA expression could be demonstrated in the non­
human primate.
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7.1 Methods.
The general methods described in Chapter 2 were employed. In these experiments, 
chronically instrumented fetal lamb preparations were used.
7AA Obtaining fetal and neonatal lamb ductus arteriosus
Pregnant Rambouillet-Colombia ewes and baboons of known gestational age were 
anaesthetised (ketamine induction, then halothane), the fetus was delivered by Caesarean 
section, and exsanguinated. Neonatal Rambouillet-Colombia lambs were anaesthetized 
with halothane and exsanguinated.
7.7.2 Instrumented fetal lamb preparations
Rambouillet-Colombia ewes bred on a single occasion and of known gestational age were 
acclimated to the animal facilities for at least 5 days before surgery and kept in rooms 
with controlled light/dark cycles. Alfalfa cubes and water were provided ad libitum. 
Surgery was performed at 104+1 (mean + SEM) days gestational age (dGA). Anaesthesia 
was induced with ketamine and maintained with halothane. Catheters were inserted into 
the ewe's carotid artery and jugular vein, into the fetal carotid and axillary arteries and 
jugular and pedal veins, and into the amniotic cavity. Electrodes were implanted 
bilaterally on the fetal parietal bone and above the orbit and on each side on the surface 
of the maternal uterine body and pregnant horn.
After surgery the ewe was returned to a metabolism cage and provided free access to 
food and water. Animals were allowed at least five days of post-operative recovery and 
all ewes received a daily antibiotics (ampicillin) and twice daily analgesics 
(phenylbutazone, until day three post-op).
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Animals were randomly assigned to receive dexamethasone (n=4) or vehicle (n=4) at 110 
dGA. Infusion of either vehicle or dexamethasone (2.2 pg/kg/min at 1 ml/h) was 
maintained for forty two hours. Immediately preceding and following the infusion, the 
fetuses were exposed to a continuous series of 2  minute infusions of phenylephrine (2 .5 , 
5, 10, 20, and 40 jug/min) and, after a 60 minute recovery period and a set of fetal and 
maternal blood samples, a continuous series of 2  minute infusions of nitroprusside ( 1 , 2 , 
4, 8 , and 16 pg/min). Infusion of either phenylephrine or nitroprusside was stopped if the 
change in blood pressure exceeded 30% of baseline or if arrhythmia was noted on the 
pressure tracing. Ewes were euthanised by intravenous injection of pentobarbital sodium 
solution (Fatal-Plus, Vortech Pharmaceuticals, Dearborn, MI).
7,1.3 Instrumented fetal baboons
Five pregnant baboons (Papio sp.) of Icnown gestational age were employed as described 
in Chapter 2. At 118-134 days of gestational age (dGA, term = 185dGA) animals were 
instrumented under halothane (1-2% in 2 1/min 02) general anaesthesia. Maternal 
femoral artery and vein and fetal carotid artery catheters were placed and a 22G catheter 
was used for fetal carotid cannulation. Five electrodes (New England Wire Corp., Lisbon, 
New Hampshire) were implanted on the uterine body for electromyographic recording of 
uterine activity.
On the morning of the fifth day after surgery, animals were given an intra-muscular 
injection of 87.5pg/kg betamethasone (Celestone, betamethasone sodium phosphate 
injection, USP, Schering Corp., Kenilworth, NJ;) or vehicle. A total of 4 doses at 12 hour 
intervals were given and the fetus was delivered by Caesarean section 12 hours after the 
last dose. In addition, further baboon fetuses were delivered by plamied Caesarean 
section as described in Chapter 2.
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7.2 Results.
Northern analysis demonstrated clear signals for the EP4 and EP3 receptor genes from 
RNA extracted from fetal and neonatal lambs (Figure 7.1). The size of transcripts was 
similar to other reports of sheep prostanoid receptors in non-vascular tissue The blots 
were also probed with riboprobes for the EP,, EP], FP and IP receptors, but none of these 
probes resulted in a signal that was clearly greater than background.
The level of expression of the EP4 receptor gene in lambs at approximately 1 lOdGA was 
not significantly different comparing un-instrumented lambs and instmmented Iambs 
receiving vehicle or dexamethasone infusion (Table 7.1). However, EP4 receptor gene 
expression was significantly lower in late term fetuses (145dGA) and lower still in 
neonates (Table 7.1, Figures 1 and 2). The pattern of EP4 expression and statistical 
significance was similar when expression was normalized to either beta-actin or 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Table 7.1 and Figure 7.2). The 
level of expression of the 4.2 kB EP3 receptor gene transcript was similar in all the 
groups studied (Figure 7.3 A and Table 7.1). The ratio of the size of the EP4 signal to the 
4.2kB EP3 signal was lower in late gestation and lower still in neonates (Table 7.1 and 
Figure 7.3B). The results were virtually identical for the 7.5 and 3.5 IcB EP3 transcripts 
(data not shown).
Samples were available from a number of fetal baboons, both controls and four steroid 
treated animals (Figure 7.4). In these animals there was no reduction in the level of EP4 
mRNA expression following treatment with betamethasone (Figure 7.5).
In situ hybridization of the baboon ductus confirmed that the gene was expressed in the 
smooth muscle cells of the vessel and demonstrated the specificity of the EP4 signal for 
the ductus over the aorta (Figure 7.6A and C). The hybridization was specific as 
confirmed by the use of a sense probe (Figure 7.6B).
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Figure 7.1. Northern blot of fetal and neonatal lamb mRNA, probed for EP4, EP3, 
beta-actin and GAPDH genes. One microgram of polyadenylated RNA was loaded in 
each lane. The estimated size of transcripts is expressed in kilobases (kB). Lanes 20 and 
31 were not used in subsequent analysis due to the absence of a reliable signal to either 
GAPDH or beta-actin. Numbers equal gestational age at time of delivery, e.g. 145 = 
animals delivered at 145 days gestational age. “ llOd uninst” = un-instrumented animals 
at 1 1 0  days, “con” = instrumented animals at 1 1 0  days acting as controls for 
dexamethasone (received vehicle), “dex Rx” = instrumented animals treated with 
dexamethasone. All other animals un-instrumented.
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Figure 7.2. Densitometric quantitation of EP4 signal in each of the seven groups 
relative to beta-actin. Key to X axis; un-instrumented at 110 days ('UN', n=3), 
instmmented and treated with dexamethasone vehicle at 110 days ('CON’, n=4), 
instmmented and treated with intravenous dexamethasone at 110 days ('DEX', n=4), un- 
instmmented at 125 days ('125', n=5), un-instmmented at 135 days ('135', n=4), un- 
instmmented at 145 days ('145', n=8 ), un-instmmented neonates ('NEO', n=4). Groups 
with the same letter were statistically significantly different during post-hoc multiple 
comparisons (Tukey’s method).
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Figure 7.3. Densitometric quantitation of 4.2kB EP3 transcript to A. ratio of EP3 to 
beta-actin B. ratio of EP4  to EP3 in each of the seven groups. Key to X axis: un- 
instrumented at 110 days ('UN', n=3), instrumented and treated with dexamethasone 
vehicle at 110 days ('CON’, n=4), instrumented and treated with intravenous 
dexamethasone at 110 days ('DEX', n=4), un-instrumented at 125 days ('125', n=5), un- 
instrumented at 135 days ('135', n=4), un-instrumented at 145 days ('145', n=8 ), un- 
instrumented neonates ('NEC, n=4). Groups with the same letter were statistically 
significantly different during post-hoc multiple comparisons (Tukey’s method).
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Figure 7.4. Northern blot of fetal baboon ductus arteriosus probed for EP4 gene and 
beta-actin. 0.5pg of polyadenylated RNA was loaded in each lane, except lane two, 
where 0.35pg was loaded. The estimated size of transcripts is expressed in kilobases 
(kB). Lane l = 128dGA, un-instrumented; Lane 2=133dGA, instrumented, vehicle control 
for betamethasone; Lane 3=blank; Lanes 4-7, all instrumented and exposed to maternally 
administered betamethasone (dGA in order: 124, 127, 129, and 137); Lane 8=blank; Lane 
9=un-instrumented 153dGA, Lane 10 = un-instrumented 158dGA.
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Figure 7.5. Densitometric quantitation of ratio of EP4  signal to beta-actin in baboon 
ductus arteriosus. “Control” = 128 dGA, un-instrumented and 133 dGA, instrumented, 
vehicle control for betamethasone. “Betameth” = all instrumented and exposed to 
maternally administered betamethasone (dGA in order: 124, 127, 129, and 137). 
“>150dGA” ^ un-instrumented 153dGA and un-instrumented 158dGA. One way 
ANOVA of the three groups: P=0.35. Unpaired t-test of spécifié hypothesis that EP4 
expression was lower in the betamethasone treated animals compared with “Control”: 
p=0.97.
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Figure 7.6. In situ hybridisation of ËP4 receptor gene expression in baboon ductus 
arteriosus and aorta. Sections from un-instrumented animal delivered by Caesarean 
section at 172 days gestational age, having received no antenatal drug treatment. A. Dark 
field, anti-sense probe, B. Dark field, sense probe, C. Haematoxylin and eosin section, 
anti-sense probe, EP4 signal visualized as silver grains. A and B, low power: ductal tissue 
in middle of field. C, high power: ductal tissue on upper left of field and aorta on lower 
right.
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Table 7.1. Three way analysis of variance: effect of fetal surgery, dexamethasone 
and gestational age and birth on expression of prostanoid receptor genes.
Fetal surgery 
P=
Dexamethasone
P=
Gestational age & birth 
P=
EPVbeta-actin 0.35 0.65 <0 . 0 0 1
EP4/GAPDH 0.36 0.31 <0 . 0 0 1
EPg/beta-actin 0 . 2 2 0.60 0.36
(4.21cB transcript)
EP4/ EP] 0.28 0.79 <0 . 0 0 1
(4.21cB EP]
transcript)
GAPDH denotes glyceraldehydes-3-phosphate dehydrogenase, kB denotes kilobases.
- 126-
7.3 Discussion
The main finding reported in this chapter is that expression o f the gene encoding the 
prostanoid EP4 receptor in the ductus arteriosus was lower in term fetal lambs compared 
with preterm lambs, and was lower still in neonatal lambs. However, there was no 
variation in expression of the gene encoding the contractile EP3 receptor in the same 
animals. The main role of the EP4 receptor in the control o f the ductus had been thought 
to be to modulate variation in the local and circulating concentrations o f PGE] The 
present data suggests that variation in the level o f the EP4 receptor gene may itself have a 
role in the control o f the vessel. It seems likely that an altered balance o f EP4 and EP3 
mediated effects on the ductus, in the face of a given concentration of PGE2, has a role in 
promoting contraction of the vessel in neonatal life.
The EP4 receptor appears to be important in the control o f the ductus with conservation in 
a number of species. It was first demonstrated in rabbits and subsequently in mice 
In the present study I have now demonstrated expression of the gene encoding the 
receptor in the lamb and baboon ductus arteriosus (Figures 7.1 and 7 .4), Given this high 
degree o f species conservation, it seems likely that the EP4 receptor will have a similar 
key role in the control o f the human ductus. This is supported by the high sensitivity of 
the human ductus to PGE]. In human infants with ductus dependent heart defects the 
vessel is dilated by exogenous synthetic PGE] in the sub-nanomolar range o f circulating 
concentrations This is consistent with the known EC50 for the EP4 receptor, which is 
more sensitive to PGE] than the other inhibitory EP receptor, the EP] receptor ' :^^2;i98;238 
The current findings help explain the apparently paradoxical observation that the ductus 
is patent in utero in EP4 null mutant mice, but fails to close following birth Taken at 
face value, this finding might be thought to suggest that the EP4 receptor somehow 
mediates contraction of the vessel in neonatal life. This is implausible both from the
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pharmacological perspective, as the receptor mediates relaxation o f ductal smooth muscle 
and on the basis of the current findings, since birth was associated with a decrease in 
expression o f the EP4 receptor gene (Figures 7.1 and 7.2). A major factor in the control of 
the ductus is the vessel's intrinsically very high level of endogenous contractile tone: 
acute withdrawal of PGEi-mediated inhibition using a PG synthesis inhibitor 
(indomethacin) results in ductal closure and fetal heart failure The ductus o f the EP4 
null mouse does not contract in response to indomethacin I hypothesize that the high 
level o f EP4 receptor-mediated inhibition o f ductal tone is essential for the normal 
development of the vessel's intrinsic tone in utero. Since contraction of the vessel 
following birth is dependent on the vessel's intrinsic contractile tone, this model would 
explain the apparent paradoxical finding of patent ductus arteriosus in EP4 null mutant 
mice This model would also explain the observation that human fetuses exposed to 
indomethacin in utero are more likely to have a patent ductus arteriosus in neonatal life 
than infants bom at a similar gestational age that were not exposed to indomethacin 
The lack o f effect o f corticosteroids on the expression o f the EP4 and EP3 receptor genes 
was o f interest. It had previously been shown that treatment with corticosteroids 
decreased the sensitivity of the preterm lamb ductus to the effects of exogenous PGE2 
On the basis o f the current data, it seems that this is unlikely to be due to variation in the 
relative balance of EP4 and EP3 gene expression. However, I cannot rule out altered 
translation o f EP4 and EP3 mRNA following steroid treatment or an effect of 
corticosteroid on receptor mRNA transcription in late gestation and following birth. 
Furthermore, steroids may also affect the balance o f EP4 and EP3 mediated effects by 
altering transcription and/or translation of other genes which might affect the relative 
balance o f activation of the two receptors, such as genes encoding G-proteins and second 
messengers. However, it is of interest that there was a decrease in expression of the EP4
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receptor gene with advancing gestational age, but no apparent change following exposure 
of the preterm fetal lamb to corticosteroids (Figure 7.2). Many of the effects of advancing 
gestational age can be induced by antenatal exposure of the preterm fetus to 
corticosteroids and the use of corticosteroids is widespread in the management of 
threatened preterm delivery, as a means of advancing pulmonary maturity The present 
study demonstrates an effect of gestational age which was not induced by exogenous 
corticosteroids, despite the fact that corticosteroids have been shown to affect other 
aspects of ductal function in the preterm lamb This underlines the potential 
importance of endocrine systems other than the adrenocortical system in ontogenic 
development of the fetus. Thyroid hormones also have maturational effects on the 
preterm fetus and been shown to alter contractility of the ductus 
It is possible, however, that the apparent lack of effect of corticosteroids is artefactual. It 
may represent a type II error due to lack of statistical power. However, using the standard 
deviations obtained from densitometry, I estimate that with an n of 4 in each group, the 
analysis had 71% power to detect the same magnitude of difference with steroid 
treatment as was observed comparing I lOdGA and l45dGA fetuses. The apparent lack of 
effect of steroids may be methodological, e.g. the dose of corticosteroid was 
insufficiently high to induce altered gene expression. However, as in previous studies, the 
fetus was noted to be hypertensive during steroid treatment, both the lambs (unpublished 
data, Koenen, Nijland and Nathanielsz, 1999) and baboons which suggests that the 
dose was not sub-therapeutic. Finally, the instrumented lambs were also exposed to both 
phenylephrine and sodium nitroprusside as part of another experiment. Administration of 
these drugs may have altered prostanoid receptor gene expression and masked an effect 
of dexamethasone. This seems unlikely, however, as there was no difference in EP4 gene 
expression among llOdGA fetuses, comparing un-instrumented animals and
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instrumented animals which were controls for dexamethasone and received 
phenylephrine and sodium nitroprusside (Table 7.1).
A study of the ductus arteriosus in piglets demonstrated several important species 
differences with respect to prostanoid receptors in the vessel These authors 
demonstrated the presence of EP2, EP3 and EP4 receptors in the fetal piglet ductus, but 
that only EP2 receptors were present in the neonatal piglet ductus. This is in contrast to 
the fetal rabbit ductus which does not express functional EP2 receptors, as evidenced by 
the lack of response to the selective EP2 agonist, AH 13205 It is also suggests species 
differences in terms of the EP4 receptor, which continued to be expressed at the level of 
mRNA in the neonatal ductus in the mouse and in the present study (albeit at lower 
levels) in the lamb, and in terms of the EP3 receptor since, in the present study, 
expression of EP3 mRNA was observed in the ductus from neonatal lambs. Furthermore, 
since the EP3 receptor mediates contraction of the ductus it remains to be seen how 
loss of this receptor might be involved in ductal closure in the neonatal piglet.
Another aspect of prostanoid receptor pharmacology which appears to differ in the fetal 
piglet when compared with other species is the affinity of EP receptor sub-types. The 
neonatal piglet ductus expressed only EP2 receptors, whereas the fetal ductus expressed 
approximately equivalent levels of EP2, EP3 and EP4 receptors The EPi receptor has a 
five to tenfold lower affinity for PGE2 than either the EP3 or EP4 receptor, which has 
been observed in functional studies in a number of species and confirmed in 
recombinant mouse prostanoid receptors However, PGE2 was bound with greater 
affinity in neonatal ductus than fetal ductus (Kd, 6.InM versus lO.SnM, respectively), 
despite the apparent loss of receptors which bind PGE2 with five to tenfold greater 
affinity than the EP2 receptor in other species. Taken together, these observations suggest 
that the piglet ductus may be somewhat atypical in terms of prostanoid pharmacology.
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Since the expression of EP receptor sub-types in the neonatal ductus is highly relevant for 
the development of drugs for the clinical manipulation of the human ductus, the 
expression of EP receptors in primate neonates should be an area of further study.
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Chapter 8 . The effect of labour and gestational age on expression of lipoxygenase 
genes in intra-uterine tissues
A large number of studies have underlined the key role of PGs in the control of 
parturition in a number of species PGs are formed from AA by one of two isoforms of 
the enzyme COX. Expression of the inducible form of this enzyme (COX-2) has been 
shown to increase both with advancing gestational age and labour and these
studies led directly to clinical studies of selective COX-2 inhibitors in the management of 
preterm labour
The PG pathway is only one of several pathways of AA metabolism which results in 
biologically active products Others include the epoxide pathway (cytochrome P450) 
the isoprostane pathway (non-enzymatic generation of isoprostanes such as 8-epi- 
PGFza) and the LOX pathway The last of these generates HPETE compounds which 
are metabolised to a range of eicosanoids, including the leukotrienes (LTs) and some of 
these compounds have been shown to have effects on myometrium 
Whereas the expression of COX genes has been systematically studied in a number of 
species, there are few studies systematically addressing variation in the expression of 
LOX genes with advancing gestation and in relation to labour. In this chapter I report 
expression of the three main recognized human LOX genes in myometrium (both fundus 
and lower segment), cervix, decidua and chorion.
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8.1 Methods
The same animals described in Chapter 4 were employed and the general methods were 
as outlined in Chapter 2. All LOX probes were cDNA.
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8.2 Results.
Clear signals of similar size to previous reports of Northern analysis of human RNA were 
detected using the 5-LOX and platelet-12-LOX probes in myometrium (Figure 8.1), 
cervix (Figure 8,2), decidua (Figure 8.3) and chorion (Figure 8.4). In the case of 5-LOX 
there was a single band of approximately 2.4kB. In the case of platelet-12-LOX there was 
a single band of 2.5kB in decidua, but in myometrium, cervix and chorion, there was also 
an additional band at 2.2kB. A clear 6.3kB band was observed using the human 15-LOX 
cDNA probe in myometrium and cervix (Figure 8.5). However, this differs markedly in 
size from previous reports of the 15-LOX gene in Northern analysis of human tissues 
and it remains to be determined whether this signal truly represents the baboon 15-LOX 
gene. No signal in any tissues was observed using the murine leukocyte 12-LOX cDNA 
probe.
Expression of the 5-LOX gene (relative to beta-actin) decreased in the cervix with 
advancing gestational age, but did not vary significantly with gestational age in any of the 
other tissues (Table 8.1). Expression of 5-LOX was greater in decidua obtained from 
animals in labour than animals not in labour, whereas 5-LOX expression in chorion was 
lower in tissues obtained from animals in labour (Figure 8.6). There was no significant 
difference in 5-LOX expression comparing labour and not in labour in either cervix or 
myometrium, and myométrial expression was not significantly different comparing 
samples obtained from the fundus and lower segment (Table 8.1).
Expression of the 2.5 kB transcript of the platelet 12-LOX gene (relative to beta actin) 
decreased with advancing gestational age in chorion, but did not vary significantly with 
advancing gestational age in any of the other tissues (Table 8.1). Expression of the 2.5 kB 
transcript of the platelet 12-LOX gene in cervix was lower in tissues obtained from 
animals in labour (Figure 8.7A). There was no significant difference in the 2.5 kB
- 134-
transcript of the platelet 12-LOX gene comparing labour and not in labour in 
myometrium, decidua or chorion and myométrial expression was not significantly 
different comparing the fundus and lower segment (Table 8.1).
Although the 2.2kB platelet 12-LOX transcript was also observed in myometrium and 
chorion, the signals were too weak for meaningful quantitative analysis. When related to 
beta-actin, there was no significant change in the level of expression of the 2.2kB 
transcript in association with either advancing gestational age or labour in the cervix 
(Table 8.1). The ratio of expression of the 2.5kB platelet 12-LOX gene transcript to the 
2.2kB transcript was lower in cervical tissue obtained from animals in labour (Figure 
8.7B) but there was no change in the ratio of the two transcripts in association with 
advancing gestational age in the cervix (Table 8.1).
The apparent 15-LOX signal showed no variation with either gestational age or labour in 
myometrium and cervix (Figure 8.5).
All cases where significant variation was observed when signals were related to beta- 
actin were also significant when related to at least one of the other two housekeeping 
genes (data not shown). Where signals were observed to change with gestational age 
prior to labour (namely, 5-LOX in the cervix and platelet 12-LOX in the chorion) 
adjusting the comparison between animals in labour and not in labour for the effect of 
gestational age (using analysis of covariance) did not alter the statistical significance.
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Figure 8.1. Northern blot of LOX expression in myometrium from lower uterine 
segment (LUS) and fundus (FUN), from animals not in labour (NIL) and in labour 
(LAB). A. 5-LOX, B. platelet 12-LOX. The estimated size of transcripts is given in 
kilobases (kB). 2pg of RNA was loaded in each lane. Lanes: A. 1-10 LUS, NIL; 11-15 
LUS, LAB; 16-25 FUN, NIL; and 26-30 FUN, LAB. B. 1-9 LUS, NIL; 10-14 LUS, 
LAB; 15-23 FUN, NIL; 24-28 FUN, LAB.
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Figure 8.2. Northern blot of LOX expression in cervix from animals not in labour 
(NIL) and in labour (LAB). A. 5-LOX, B. platelet 12-LOX. The estimated size of 
transcripts is given in kilobases (kB). 4pg of RNA loaded in each lane in A and 2pg 
loaded in each lane in B. Both blots, lanes 1-7 NIL and lanes 9-13 LAB.
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Figure 8.3. Northern blot of LOX expression in decidua from animals not in labour 
(NIL) and in labour (LAB). A. 5-LOX, B. platelet 12-LOX. The estimated size of 
transcripts is given in kilobases (kB). 5 pg of RNA loaded in each lane. Lanes: A. 1-8 
NIL, 9-13 LAB; B. 1-9 NIL, 10-14 LAB.
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Figure 8.4. Northern blot of LOX expression in chorion from animals not in labour 
(NIL) and in labour (LAB). A. 5-LOX, B. platelet 12-LOX. The estimated size of 
transcripts is given in kilobases (kB). 5 pg of RNA loaded in each lane. Both blots, lanes 
1-7 NIL and lanes 9-13 LAB.
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Figure 8.5. Northern blot of 15-LOX expression in A. Myometrium, B. Cervix.
Samples of myometrium from both lower uterine segment (LUS) and fundus (FUN), and 
samples from both tissues obtained from animals not in labour (NIL) and in labour 
(LAB). The estimated size of transcripts is given in kilobases (kB). Lanes: A. 1-9 LUS, 
NIL; 10-14 LUS, LAB; 15-24 FUN, LAB; and 25-29 FUN, LAB. B. 1-7 NIL and 9-13 
LAB. Statistical comparison (densitometry relative to beta-actin): A. FUN vs. LUS, 
p=0.19 (ANOVA), NIL vs. LAB, p=0.18 (ANOVA); B. NIL vs. LAB, p=0.38 (Student’s 
t-test). Similar results obtained when signal quantified relative to GAPDH or cyclophilin.
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Figure 8.6. Densitometric analysis of 5-LOX expression (relative to beta-actin) 
decidua and chorion. A. Decidua and B. Chorion, comparing animals in labour (LAB, 
n=5) with animals not in labour (NIL, n=7-8). Columns are means, bars are SEM. 
Statistical comparison by Student’s t-test.
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Figure 8.7. Densitometric analysis of 12-LOX expression in the cervix. A. 2.5kb 
transcript relative to beta-actin and B. 2.5kb transcript relative to 2.2kb transcript, 
comparing animals in labour (LAB, n=5) with animals not in labour (NIL, n=7). Columns 
are means, bars are SEM. Statistical comparison by Student’s t-test.
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Table 8.1. Expression of 5-LOX and platelet 12-LOX in relation to gestational age 
and labour in baboon intra-uterine tissues.
5-lipoxygenase Platelet 12-lipoxygenase^
Means (SEM) P =
NIL
(n=7-lO)
LAB
(n=5)
GA
(NIL) LAB
Means (SEM)
NIL LAB 
(n=7-10) (n=5)
P =
GA
(NIL)
LAB
LUS
Fundus
Fundus*
labour
Cervix
Decidua
Chorion
0.25 0.35
(0.03) (0.10)
0.39 0.34
(0.05) (0.09)
1.23 1.11
(0.28) (0.22)
0.59
(0 . 12)
0.65
(0.05)
1.05
(0.11)
0.42
(0.08)
0.96
0.77 0.69
0.20
0.02 0.75
0.72 0.02
0.56 0.02
0.49 0.24
(0.14) (0.04)
0.38 0.26
(0.13) (0.07)
2.5kB:
0.60
(0.05)
2.2kB:
0.46
(0.05)
ratio:
1.33
(0.07)
0.90
(Ori7)
0.23
(0.04)
0.37
(0.05)
0.37
(0.06)
1.02
(0.03)
0.62
(0.20)
0.20
(0.02)
0.57
0.69
0.79
0.68
0.95
0.02
0.33
0.17
0.02
0.27
0.61 0.004
0.32
0.51
^Unless stated otherwise, expression of platelet 12-LOX refers to the 2.5kB transcript.
GA denotes gestational age, NIL denotes not in labour, LAB denotes in labour, kB 
denotes kilobases, SEM denotes standard error of the mean.
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8.3 Discussion.
A key role has been established for PGs in the control of labour in a number of species 
The elucidation of the physiological role of PGs in labour led directly to the clinical use 
of PG synthesis inhibitors in preterm labour, and these drugs are currently widely 
clinically employed The PG pathway is, however, just one of several pathways 
through which AA can be metabolised. Much less is understood about the role of these 
other pathways in the control of parturition. A wide range of drugs have been developed 
which both inhibit LOX enzymes and block receptors through which LOX products act 
247;248 LOX products havc a role in parturition, there is the potential for these drugs to 
be employed in the clinical management of preterm labour. A key line of evidence in 
understanding the role and site of PG synthesis in the control of parturition was 
elucidation of quantitative changes in COX gene expression in association with labour 
25,245 aim of the present study was, therefore, the systematic study of LOX gene 
expression in key intra-uterine tissues with advancing gestational age and labour.
The three main LOX genes identified in the human are 5-LOX, platelet 12-LOX and 15- 
LOX In the mouse there is another isoform, namely, leukocyte 12-LOX. However, this 
enzyme also has 15-LOX activity and shares 65% amino acid homology with human 15- 
LOX It is thought that murine leukocyte 12-LOX is the homologue of 15-LOX in the 
human and, consistent with this hypothesis, I could not detect leukocyte 12-LOX 
expression in any of the baboon tissues. The signals observed in the present study using 
the 5-LOX and platelet 12-LOX probes were similar to previous reports of Northern 
analysis in human tissues However, the transcript observed using the 15-LOX
probe was approximately twice as large as previous descriptions of Northern blot of 
human tissue I have reported these findings with this probe for completeness (Figure
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8.5), but suggest that the results be interpreted with some caution until more is known 
about the baboon 15-LOX gene.
The changes observed in expression of 5-LOX were tissue specific. Expression of the 
gene decreased with advancing gestational age in cervix and was lower in animals in 
labour in chorion. However, 5-LOX expression was greater in decidua obtained from 
animals in labour. Increased 5-LOX expression suggests that 5-HPETE or its metabolites 
might promote parturition. This could either be due to autocrine effects on the decidua or 
paracrine effects on myometrium. Consistent with this, 5-HETE has been shown to 
stimulate contractility in myométrial strips obtained from the LUS of pregnant women 
The decrease in 5-LOX expression in cervix and chorion may indicate that in these 
tissues, 5-HPETE or its metabolites may act to inhibit the process of parturition. 
Consistent with this hypothesis, LTB4 has been shown to exert inhibitory effects on 
cervical tissue obtained from pregnant women at term An alternative possibility is 
that 5-HPETE and its metabolites are without significant effects in these tissues and that 
the main biological consequence of lower levels of 5-LOX expression may be to divert 
free AA to the PG pathway. These mechanisms may also act additively, since exogenous 
LTB4 has been shown to inhibit PGE2 release in human fetal membranes Therefore, 
decreased 5-LOX may stimulate PGE2 release due to both an increase in the free AA pool 
and direct effects of LTs on PG biosynthesis.
The size of the platelet 12-LOX transcript observed in the baboon (2.5kB) was very 
similar in size to the human transcript (2.4kB) which supports the interpretation that this 
signal is likely to represent the platelet 12-LOX gene in the baboon However, in 
myometrium, cervix and chorion a second transcript of 2.2kB was also observed. The 
level of expression of the smaller transcript was lower than the 2.5kB transcript and 
quantitative analysis of the level of expression was only possible in cervix. Interestingly,
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labour appeared to affect differentially expression of the two transcripts in the cervix 
(Figure 8.2, Table 8.1). The practical significance of these observed changes in relative 
expression is as yet unclear although isoforms of 12-LOX have previously been described 
However, the fact that changes were observed is consistent with a role for platelet 12- 
LOX, in some form, in the control of parturition in these tissues. As in the case of 5-LOX 
this could be by effects on PG synthesis or by effects of 12-HPETE (or its metabolites) 
on key intra-uterine tissues. It has been shown that 12-HETE had no effect on the 
contractility of isolated strips of human myometrium As in the case of 5-LOX, it may 
be that reduced platelet 12-LOX activity might be a factor in determining increased PG 
levels in labour, amplifying the effect of other known factors which increase PG 
synthesis in labour such as increased expression of PLA2 and COX-2 
Comparing the findings of this study with other studies, it has also been shown in the 
human that mRNA encoding the 5-LOX gene increases in the choriodecidua in 
association with labour and this was paralleled by increased 5-LOX protein This is 
consistent with the observation that amniotic fluid concentrations of both 5-HETE and 
LTC4 are higher in women in samples obtained from women in labour compared with 
women not in labour The finding that 5-LOX and 12-LOX were the main LOX
enzymes in intra-uterine tissues is consistent with biochemical studies of human intra­
uterine tissues that have demonstrated that 5-HETE and 12-HETE are the main LOX 
products of AA in human intra-uterine tissues My hypothesis that decreased 12-
HETE formation in labour may play a role in increasing free AA and thus promoting 
formation of PGs is supported by the observation that 12-HETE is quantitatively the 
major AA metabolite formed in key intra-uterine tissues and that human labour is 
associated with an increased ratio of COX: LOX metabolites of AA
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There were no apparent differences in myométrial expression of LOX genes comparing 
the upper and lower segment of the uterus. This is in contrast to COX genes which have 
been shown to demonstrate differential expression according to uterine site in the baboon 
These observations also tend to support an interpretation of different physiological 
roles for COX and LOX products in the control of parturition.
These data do not strongly suggest, at present, a potential role for LOX inhibitors in the 
treatment of preterm labour. Indeed, the observations that both advancing gestational age 
and labour are associated with decreases in the expression of some LOX genes in key 
tissues suggests that pharmacological inhibition of LOX genes may actually promote 
parturition by diverting free AA to the PG pathway. However, increased expression of 5- 
LOX in decidua is consistent with a possible role for 5-LOX products (such as 
leukotrienes) in parturition. Multiple receptors exist for these compounds and drugs with 
selective antagonist activity have been described Unlike enzyme inhibitors, receptor 
antagonists would not be expected to increase the pool of free AA and the effect of 
available drugs on parturition in animals wairants study.
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Chapter 9. Overall conclusions.
The specific aims outlined in Chapter 1 were largely achieved. The immediate 
significance of observations to a given area of study were discussed in each chapter. The 
purpose of this chapter is, briefly, to draw together these observations into such general 
conclusions as can be drawn from this work.
9.1 Variation in prostanoid receptor expression with advancing gestational age and 
labour
As outlined in Chapter 1, there has been a great deal of study of the regulation of the 
genes which control PG concentrations in key intra-uterine tissues during parturition. One 
of the key aims of this thesis was to determine whether variation in the level of 
expression of the receptors may also have a role in the control of primate parturition. This 
aim was achieved and I demonstrated variation in the level of expression of genes 
comparing animals in labour and animals not in labour in myometrium, cervix, decidua 
and chorion. Of particular significance was the observation that expression of the 
prostanoid EP? receptor gene was lower in labour in myometrium (both lower segment 
and fundus [Chapter 4]), cervix (Chapter 5) and decidua (Chapter 6). This gene encodes 
an adenylate cyclase coupled receptor which typically inhibits myométrial contractility. I 
speculate that this gene may also exert inhibitory effects in the cervix and decidua and 
that loss of EPi receptor mediated inhibition in these tissues may be a key molecular 
event in primate parturition. I also demonstrated that in a key, PG mediated fetal adaptive 
response at birth, namely, contraction of the ductus arteriosus, one could demonstrate 
altered expression of stimulatory and inhibitory prostanoid receptor genes. These data 
suggest that variation in the expression of prostanoid receptor genes may be a key feature 
of dynamic physiological control of smooth muscle by PGs.
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9.2 Regional variation in myométrial function
Many studies in pregnant woman have examined the function of myometrium obtained at 
the time of lower uterine segment Caesarean section The assumption (often unstated) 
of these studies was that the function of LUS myometrium is the same as myometrium 
from the corpus and fundus. In this thesis I demonstrated that this assumption is unsound. 
Variation exists in the expression of prostanoid receptor genes in tissue obtained prior to 
the onset of labour (Chapter 3) and the pattern of variation is consistent with functional 
variation in the response to native PGs Furthermore, the nature of the differences 
between the LUS and fundus is affected by labour in terms of inhibitory but not 
excitatory receptor genes (Chapter 4). These observations underline the potential pitfalls 
of studying LUS samples in isolation from the rest of the uterus. The studies also 
demonstrated that there was no regional variation in expression of LOX genes (Chapter 
8) in contrast to studies of C0X2 expression in these baboon tissues
9.3 Tissue specific expression of prostanoid receptors
In the initial screen of expression of receptor genes, it was apparent that there was 
variation in the level of expression of different prostanoid receptor types and sub-types 
comparing different intra-uterine tissues (Chapter 3). When levels of expression were 
then compared in samples obtained at the time of labour and from animals prior to the 
onset of labour, it was observed that certain genes changed in some tissues but not others. 
For instance, there was a lower level of expression of the prostanoid EP? receptor gene in 
maternal intra-uterine tissues (Chapters 4-6) but not chorion (Chapter 6). In contrast, IP 
receptor gene expression was increased in both decidua and chorion (Chapter 6), but did 
not significantly differ in relation to labour in myometrium (Chapter 4) or cervix
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(Chapter 5). These observations suggest that different PGs may have differential effects 
on different intra-uterine tissues and, consequently, that drugs with selective activity at 
prostanoid receptor types and sub-types may allow more specific manipulation of intra­
uterine tissues.
9.4 Cell specific expression of prostanoid receptors
A number of lines of study in this thesis demonstrated that even in a given tissue a given 
second messenger system could not be characterized as either inhibitory or stimulatory. 
This possibility was underlined by findings in the decidua. Labour was associated with 
lower levels of expression of the EPz receptor gene but higher levels of expression of the 
IP receptor gene (Chapter 6 ). Both receptors are coupled to adenylate cyclase This 
suggests that in cells which express the EP] receptor, cAMP dependent protein kinases 
have effects which inhibit the process of labour, whereas in cells expressing the IP 
receptor the same enzymes may have effects which promote parturition. The potential for 
these observations to have rational physiological explanations was apparent using in situ 
hybridization in myometrium which demonstrated differential expression of the 
prostanoid EP3 receptor in myométrial and vascular smooth muscle (Chapter 4). This is 
likely to be due to the fact that uterine resistance vessels should be most widely dilated 
when uterine smooth muscle is most intensely activated.
9.5 The concept of stimulatory and inhibitory systems
The factors regulating myométrial contractility have been the natural focus of studies of 
the control of parturition. This reflects a key role for uterine contraction in the process of 
labour, but also probably also reflects the relative ease of study of myométrial function. 
Techniques have been available for more than 50 years that allow the study of the effects
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of drugs on myométrial contractility. However, as discussed elsewhere in this thesis, 
other intra-uterine tissues have keys roles in the process of parturition, such as the fetal 
membranes and cervix. However, it is much less straightforward to characterize the effect 
of a drug on the process of cervical priming or the integrity of the fetal membranes than 
uterine contraction. This has led both to the natural focus on myometrium and a tendency 
to characterize a given system as either promoting or inhibiting the process of parturition 
on the basis of its effect on myométrial contractility. It is clear, however, that the simple 
fact of a drug having an inhibitory effect on myométrial contractility does not ensure that 
the same drug will inhibit the processes leading to expulsion of the fetus in the other key 
intra-uterine tissues. A recent, important clinical example of this is nitric oxide, which 
inhibits myométrial contractility but which promotes the process of cervical ripening
174:222
The current studies also demonstrated that receptors which would be anticipated to 
stimulate myométrial contractility were seen to have lower levels of mRNA expression in 
other tissues in association with labour. Both TP and FP receptor activation stimulate 
myométrial contractility but expression of the genes encoding both receptors was 
lower in the cervix in association with labour (Chapter 5). Conversely, IP receptor 
activation inhibits myométrial contractility but expression of the IP receptor gene was 
much higher in the chorion (and to a lesser extent in the decidua) obtained from animals 
in labour (Chapter 6). These observations suggest that key prostanoid receptor types 
might be stimulatory to the process of labour in some tissues but inhibit the process in 
others. These findings underline the necessity for caution when investigating a drug in the 
inhibition of labour on the basis of a negative effect on myométrial contractility.
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9.6 Regulation of prostanoid receptor gene transcription
It is apparent from the studies reported in this thesis that there is variation in the 
expression of prostanoid receptor genes in association with advancing gestational age and 
labour which is manifested by altered levels of expression of the same receptor gene in 
some tissues but not others, or in a given tissue of some genes but not others. These 
findings suggest that factors modulate the control of expression of these genes in labour 
within key intra-uterine cells in a tissue specific manner. The global reduction in EP2 
receptor gene expression was taken to suggest a key role for this gene in the control of 
primate parturition. If true, the factors which control the onset of parturition may possibly 
be inferred by understanding the transcriptional regulation of this gene. There are very 
few data on the factors which control expression of any of the prostanoid receptors. For 
instance, one of the basic techniques in the study of factors which control gene 
transcription is DNA foot printing. A Medline search (September 2000) failed to yield 
any citations which used the MESH terms “DNA foot printing” and “receptors, 
prostaglandin”. This area, particularly as it relates to parturition, would appear to be ripe 
for future research.
9.7 Technical considerations relating to prostanoid gene expression
Over the course of the three year project, I clearly modified the technical approach to the 
study of prostanoid receptor genes. The major change was the use of riboprobes instead 
of cDNA probes for Northern blot analysis. In my initial studies I could not detect EPi, IP 
or TP receptor signals using cDNA probes (Chapter 3). I then found that using 
riboprobes, appropriate sized transcripts could be detected for these genes (Chapter 4). 
There are a number of advantages to the use of riboprobes over cDNA probes. First, 
cDNA probes are double stranded whereas riboprobes are single stranded. The two
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complementary DNA molecules will tend to bind each other and therefore not be 
available to bind the target. In the case of riboprobes, this is not an issue. Secondly, the 
higher stability of RNA: RNA duplexes compared with DNA:RNA duplexes means 
that higher temperatures can be used for both hybridisation and washing which results in 
a higher signal to noise ratio. Thirdly, the unlabelled template DNA can be removed from 
the riboprobe using RNase free DNase I. This can clearly not be done using a cDNA 
probe. Finally, as part of the random priming process, one employs random decamers to 
create stretches of double stranded DNA to allow the Klenow DNA polymerase to 
synthesize DNA. Consequently, only a proportion of the given dNTP (for instance dCTP) 
is radioactively labelled since dCTP will also be included in the random hexamers, which 
are unlabelled. In contrast every NTP (UTP in the present study) in a riboprobe is 
radioactively labelled unless ‘cold’ UTP is added with the intention of making the probe 
less active.
Another issue is that the present study focused entirely on the expression of genes. I did 
not use other techniques to confirm that the RNA was translated into protein and that the 
protein was formed into functional receptors. The close parallel between gene expression 
and functional responses when comparing uterine regions (Chapter 3) supports my 
assumption that genes were translated. Ideally, one would employ protein analysis (such 
as immunocytochemistry or Western blot analysis) or receptor binding studies to confirm 
these assumptions. Unfortunately, antibodies are not widely available for the prostanoid 
receptor genes. Furthermore, such ligands as are available are not specific for a given 
prostanoid receptor type or sub-type .
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9.8 Summary
Many genes encoding prostanoid receptor types and sub-types are expressed in key intra­
uterine tissues and the level of expression varies systematically within the gravid baboon 
uterus in relation to anatomical site, gestational age and labour. Comparable changes 
were demonstrated in the fetal ductus arteriosus. The nature of this variation suggests that 
altered expression of prostanoid receptor genes may have an important role in the control 
of parturition and in the preparation of the fetus for birth. Drugs with selective activity at 
prostanoid receptor types and sub-types are likely to allow safer and more effective 
control of the human uterus in the clinical management of term and pre-term labour.
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